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FOREWORD
Let’s pick up the pace to beat NCDs
Last year, 2015 was an historic year for 
noncommunicable diseases (NCDs).   Global leaders, 
recognizing the enormous burden that NCDs place 
on people and communities in developed and 
developing countries, included them in the new global 
Sustainable Development Goals (SDGs).
As part of our efforts to track global progress to reduce 
premature death from preventable NCDs, WHO 
conducted, in 2015, its fifth national NCD country 
capacity survey.The aim of this survey is to generate 
detailed information from countries on their current 
capacities related to NCD infrastructure, policy 
action, surveillance and health-systems response. 
Besides providing a useful snapshot of the progress 
countries are making to beat NCDs, the WHO NCD 
country capacity survey highlights areas that urgently 
require prioritization and additional strengthening. 
The latest survey reveals that while significant progress 
is being made overall, on-going challenges persist in 
addressing NCDs in many countries. These include a 
lack of resourcing of key initiatives that can prevent 
people developing an NCD or provide care for those 
in need; weak multisectoral coordination, resulting in 
NCDs continuing to be seen as just a “health issue” in 
many countries; and difficulties in putting plans and 
strategies to address NCDs into action.  
The results of the 2015  NCD country capacity 
survey show that  we can achieve real progress 
in strengthening NCD prevention and control 
capacities. It highlights encouraging improvements 
in infrastructure and staffing in many parts of the 
world, as well as the existence of policies, plans and 
strategies to address NCDs. 
But a “business-as-usual” approach won’t suffice. 
Governments must steel themselves to achieve NCDs 
targets, embedded in the SDGs and World Health 
Assembly resolutions. Millions of people can be 
spared from developing and living with an NCD 
by governments transforming their commitments into 
action. This entails full implementation of highly cost 
effective and feasible  interventions, such as tobacco 
control; control of marketing of unhealthy foods 
and  beverages  to children;  primary health care 
interventions; and in ensuring NCDs are tackled as a 
“whole-of-government” priority.
Meeting these commitments, and reporting on them 
in early 2017 for the sixth edition of this survey, must 
be recognized for what they are – global priorities. 
Progress will have to be demonstrated in 2018 when 
world leaders meet for the third United Nations 
General Assembly High-level meeting on Non-
communicable Diseases. Continued and intensified 
action to safeguard and accelerate these positive 
trends will be vital for saving lives and improving 
health globally and achieving the ambitious targets 
we have jointly set to beat NCDs. 
Dr Oleg Chestnov
Assistant Director-General
Noncommunicable Diseases and Mental Health
World Health Organization
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EXECUTIVE SUMMARY 
Noncommunicable diseases (NCDs), including 
cardiovascular diseases, cancer, diabetes and 
chronic respiratory diseases, and their key risk factors 
– tobacco, harmful use of alcohol, unhealthy diet and 
physical inactivity – remain the leading causes of 
death globally. NCDs are currently responsible for 
almost 70% of global deaths, the majority occurring 
in low- and middle-income countries. In recent years 
NCDs have been increasingly in the spotlight of the 
global public health community and national leaders. 
Most recently, the 2030 Agenda for Sustainable 
Development Goals, adopted at the United Nations 
Summit on Sustainable Development in September 
2015, recognized the critical public health importance 
of addressing NCDs, and included a goal to reduce, 
by one third, the premature mortality from NCDs, 
along with targets to address risk factors such as 
alcohol and tobacco, and achievement of universal 
health coverage by 2030. Achieving targets for 
NCD prevention and control require a renewed and 
concerted action at the national level. Key to this is 
capacity: physical, human and at the policy level.
To assess the capacity of countries to respond to NCDs, 
WHO carries out periodic global country capacity 
surveys. The first of these was conducted in 2001. 
Subsequent surveys, intended to assess progress, were 
conducted in 2005, 2010, and 2013. The fifth, and 
most recent, survey was conducted in early 2015. In the 
2015 survey, countries were asked to provide detailed 
information on their capacity to address NCDs, and to 
determine current strengths and weaknesses in terms of 
their NCD infrastructure, policy response, surveillance 
and health-systems response. Comparisons with results 
from previous surveys will help to determine if overall 
global progress is being made.
A web-based questionnaire hosted on the WHO 
website was used to collect data from NCD focal 
points or designated colleagues within the ministry 
of health, national institute, or agency responsible for 
NCDs in all WHO Member States (194 countries). 
The survey tool included questions on (i) public 
health infrastructure, partnerships and multisectoral 
collaboration; (ii) policies, strategies and action plans; 
(iii) health information systems and surveillance; and 
(iv) health-system capacity for detection treatment and 
care. Data collection was conducted between May 
and August 2015. For validation and verification 
of responses, countries submitted supporting 
documentation for a select number of questions. 
These were then reviewed by the WHO Secretariat 
at WHO regional offices and WHO headquarters. 
Additional validation was carried out against other 
known data sources. 
In all, 91% of countries (177) responded to the survey. 
Trends in national capacity for NCDs were derived 
from comparing the results of the 2015 survey with 
those from the capacity surveys conducted in 2013 and 
2010. For the comparison of responses across these 
three surveys, analyses were limited to the 160 WHO 
Member States that completed all three surveys and 
were focused only on the questions which appeared in 
all three surveys.
Analysis of results revealed that in 2015, 93% of 
countries reported having a unit, branch or department 
responsible for NCDs within their ministry of health, 
with 91% having at least one full-time technical or 
professional staff member working within the unit, 
branch or department. The most prevalent form of 
funding was for health care and treatment, (94% of 
countries) followed by primary prevention of NCDs 
(88%), health promotion activities (87%), early detection 
and screening (85%), surveillance, monitoring and 
evaluation (81%), and palliative care (64%). Major 
sources of funding included government revenues 
(94% of countries), international donors (64%), health 
insurance (62%), and earmarked taxes (34%).
11Report of the 2015 Global NCD Survey
Thirty-four per cent (34%) of countries reported having 
an operational national multisectoral commission, 
agency, or mechanism to oversee NCD engagement, 
policy coherence and accountability of sectors beyond 
health. Fifty-three per cent (53%) of countries reported 
having an operational, multisectoral national policy, 
strategy or action plan that integrates several NCDs 
and their risk factors. 
Only 23% of countries reported having a dedicated 
office, department, or administrative division within 
the ministry of health exclusively dedicated to NCD 
surveillance. Eighty-eight per cent (88%) of countries 
reported having a system for collecting mortality data 
by cause of death on a routine basis. Fifty-nine per 
cent (59%) of countries reported having a population-
based cancer registry, and 14% a population-based 
diabetes registry. Nearly a quarter of countries (24%) 
had not conducted a recent (i.e. conducted in 2010 
or later) national adult risk factor survey, and a further 
14% reported conducting recent, national adult 
surveys for only 1–4 of the 9 main NCD risk factors.
In relation to availability of evidence-based guidelines, 
protocols or standards for disease management, 75% 
of countries reported guidelines for diabetes; 67% for 
cardiovascular diseases; 60% for cancer; and 55% 
for chronic respiratory diseases. 
The availability of standard criteria for the referral of 
patients from primary care level to a higher level of care for 
each of the four main NCDs were reported by the majority 
of countries, with diabetes criteria most prevalent (73% of 
countries), followed closely by criteria for cardiovascular 
diseases (68%) and cancer (64%). Criteria for chronic 
respiratory diseases were available in only 57% of 
countries. More than 90% of countries indicated criteria 
for each of the four main NCDs (diabetes, hypertension, 
chronic respiratory diseases and cardiovascular disease) 
were either fully or partially implemented.
The majority of countries reported having basic 
technologies generally available for early detection, 
diagnosis and monitoring of NCDs in primary-care 
facilities in the public health sector: 97% for blood 
pressure measurement, 95% for weight measurement, 
and 90% for height measurement. Blood glucose 
measurement was also widely available, with 85% 
of countries reporting general availability in primary 
care facilities in the public health sector.  
Regarding cancer screening programmes, 79% of 
countries reported availability for cervical cancer, 
followed by 76% for breast cancer, 40% for colon 
cancer, and 29% only for prostate cancer. Few of 
these were described as population-based screening 
programmes.
Sixty-seven per cent (67%) of countries reported having 
cancer centres or cancer departments at the tertiary 
level. Pathology services were generally available in 
the public health sector in 75% of countries; however 
cancer surgery (69%) and subsidized chemotherapy 
(63%) were less available.
The majority of countries reported having essential 
medicines for the management of the four main NCDs 
generally available in the public health sector. The 
most readily available medicines (in 88% of countries) 
were aspirin (100 mg) and thiazide diuretics; the least 
available (in 43% of countries) was oral morphine.
In general, palliative care for patients with NCDs in 
the public health system, in primary health care or 
as community or home-based care, was not widely 
available, with only 41% reporting availability of 
palliative care in primary health care and 36% as 
community or home-based care.
Cardiovascular risk stratification for the management 
of patients at high risk for heart attack and stroke was 
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reported as available in more than 50% of primary 
health-care facilities in just 21% of countries. Around 
a quarter (24%) reported availability of acute stroke 
care and rehabilitation in over 50% of public sector 
health-care facilities.
While the majority of high-income countries reported 
availability of retinal photocoagulation, renal 
replacement by dialysis, renal replacement by 
transplantation, coronary bypass or stenting, and 
thrombolytic therapy, less than one third of low-
income countries reported these available. 
Where possible, and to illustrate progress, the report 
includes comparisons with results of the 2010 and 
2013 surveys. Explicit comparisons, where made, 
are among the 160 countries that participated in all 
three surveys.
The 2015 NCD CCS revealed ongoing challenges in 
addressing NCDs at the national level including: a 
lack of resourcing of key initiatives; weak multisectoral 
coordination; disparities between the existence of 
policies and operational plans to address NCDs 
and their implementation, particularly in the area 
of unhealthy diet; lack of routine population-based 
surveillance; inadequate provision of NCD treatment 
and management for some NCDs; poor targeting of 
screening programmes; and very weak provision of 
palliative care for those suffering from existing NCDs. 
In general the survey revealed worrying disparities 
between high- and low-income countries, with very 
weak capacity and policy and service delivery in low-
income countries. 
Opportunities revealed in the survey included 
increased recognition of the importance of addressing 
NCDs; improved infrastructure and staffing; existence 
of policies, plans and strategies to address NCDs; 
target and indicator setting to track overall progress at 
country level; and improvements in country capacity 
across the board. 
13Report of the 2015 Global NCD Survey
Noncommunicable diseases (NCDs), including 
cardiovascular diseases, cancer, diabetes and 
chronic respiratory diseases, and their key risk factors 
– tobacco, harmful use of alcohol, unhealthy diet and 
physical inactivity – remain the leading causes of 
death globally. NCDs are currently responsible for 
almost 70% of global deaths – the majority occurring 
in low- and middle-income countries (1). In recent 
years, NCDs have been increasingly in the spotlight 
of the global public health community and national 
leaders. Two United Nations High-level Meetings, in 
2011 and 2014, have served to keep NCDs the focus 
of national and international attention and reflect 
their significant public health burden (2, 3). In 2013 
the World Health Assembly adopted a set of nine 
ambitious targets covering NCD mortality, risk factors 
and national systems performance (4). Additionally, 
the 2030 Agenda for Sustainable Development 
Goals, adopted at the United Nations Summit on 
Sustainable Development in September 2015, 
recognized the critical public health importance of 
addressing NCDs, and included a goal to reduce, by 
one third, the premature mortality from NCDs, along 
with targets to address risk factors such as alcohol 
and tobacco use, and the achievement of universal 
health coverage by 2030. Achieving these targets for 
NCD prevention and control requires a renewed and 
concerted action at the national level.  
In order to assess national capacity for NCD 
prevention and control, in 2001 WHO conducted 
the first NCD country capacity survey (NCD CCS) 
to gather detailed information on the progress of 
countries in addressing and responding to NCDs (5). 
The survey tool used in the assessment has evolved 
and expanded over time. It was intended to help 
countries assess current strengths and weaknesses 
relating to NCD infrastructure, policy response, 
surveillance, and the response of health systems to 
address NCDs at the national level. It was anticipated 
that periodic monitoring of national progress may 
assist countries in identifying gaps in NCD prevention 
and control efforts and aid future planning. The 
survey was repeated in 2005 and in 2010. Since 
2010, two surveys have been conducted, in 2013 
and in 2015; a subsequent survey is planned for 
2017. This is in response to increasing interest in the 
reporting of progress being made at the national level 
relating to the adoption of the Global Action Plan for 
the Prevention and Control of Noncommunicable 
Diseases 2013–2020 (6) (Global NCD Action Plan) 
and the national commitments made during the UN 
High-level Meetings on NCDs in 2011 and 2014. 
The objective of this report is to summarize the results 
of the 2015 NCD CCS and to identify limitations and 
challenges for national capacity for NCD prevention 
and control. Where possible, comparisons will be 
made with results of the 2010 and 2013 surveys. The 
report will also provide information to monitor progress 
relating to the objectives and recommendations of the 
Global NCD Action Plan (6), and to some of the ten 
progress indicators to monitor national commitments 
from the UN High-level Meetings on NCDs that will 
be reported at the United Nations General Assembly 
(UNGA) in 2017.
INTRODUCTION 
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Data collection, review and validation
A web-based questionnaire hosted on the WHO website 
was used to collect data from NCD focal points or 
designated colleagues within the ministry of health or 
national institute or agency responsible for NCDs in all 
WHO Member States (194 countries). Each country 
received their unique details to access the website in 
late May or early June 2015 and the focal points were 
requested to submit their completed questionnaire through 
the WHO website by the end of August 2015. In order to 
improve the quality and breadth of information provided, 
instructions requested that a team of people, led by the 
NCD focal point, complete the responses so that topic-
specific experts could provide more detailed assessment. 
Additionally, for validation and verification of responses, 
countries were asked to submit supporting documentation 
for a select number of questions. For example, for the 
question on the existence of treatment guidelines for the 
major NCDs, copies of each guideline were requested.
Upon receipt of each completed questionnaire, the WHO 
Secretariat reviewed the responses for completeness, 
and validated responses against existing data sources 
and supporting documentation submitted. For example, 
the existence of a cancer registry was validated against 
the IARC GLOBOCAN1 database, which included 
information on recognized cancer registries. Responses 
related to the collation of mortality data was checked 
against information on vital registrations systems held 
within WHO in the Department of Health Statistics 
and Informatics. Information on recent NCD risk factor 
surveys was checked against the internal survey tracking 
systems for WHO-supported risk factor surveys. These 
included WHO STEPS (adult risk factor surveillance),2 
the Global School-based Student Health Survey 
(GSHS),3  the Global Youth Tobacco Survey (GYTS),4 
and the Global Adult Tobacco Survey (GATS).5  
Where discrepancies were noted between the country 
response and these other sources, a clarification request 
was returned to the country for their consideration 
and an updating of their response. Likewise, if the 
review revealed missing documentation or incomplete 
questions, the focal point was asked to supply the missing 
information. In most cases, suggested modifications 
were adopted and the missing data and documents 
were added to the country’s response in the website.
Questionnaire
The web-based questionnaire consisted of four 
modules: (i) public health infrastructure, partnerships 
and multisectoral collaboration; (ii) policies, 
strategies and action plans; (iii) health information 
systems and surveillance; and (iv) health system 
capacity for detection treatment and care (the 
full questionnaire can be found in Annex 3). The 
questions were developed through a consultative 
process with relevant technical departments in WHO 
headquarters and all WHO regional offices, with the 
intent of obtaining objective information about each 
of these four components, as opposed to opinions 
about adequacy of capacity. Specific components of 
the questionnaire were as follows:
• The infrastructure component asked questions 
relating to the presences of a unit or division 
within the ministry of health dedicated to NCDs, 
staffing and funding, fiscal interventions including 
taxation and subsidies and the motivation for the 
fiscal interventions, and if there was a high-level 
national multisectoral commission, agency or 
mechanism to oversee NCD-related work.
• The policies, strategies and plans component 
asked questions relating to the presence of 
policies, strategies, or action plans. The questions 
differentiated between integrated policies, 
strategies, or action plans (defined as addressing 
one or more risk factor or disease) or policies, 
strategies, or action plans for a specific disease or 
risk factor. Ministries of health were asked to name 
the policy and indicate if the plan was currently in 
operation. Additionally, this component covered 
cost-effective policies for NCDs, such as policies 
to reduce population salt-consumption.
1 http://globocan.iarc.fr/Default.aspx 
2 http://www.who.int/chp/steps/en/
3 http://www.who.int/chp/gshs/en/
4 http://www.who.int/tobacco/surveillance/gyts/en/
5 http://www.who.int/tobacco/surveillance/survey/gats/en/
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Region Total number  
of countries
Number of  
responding countries
Response  
rate
AFR 47 35 75%
AMR 35 34 97%
EMR 21 20 95%
EUR 53 52 98%
SEAR 11 11 100%
WPR 27 25 93%
Total 194 177 91%
• The information systems and surveillance module 
asked questions on the routine collection of 
mortality data, the existence of cancer and diabetes 
registries and risk factor surveillance activities. 
• The health system capacity component asked 
countries to assess the capacity of their health 
system related to NCD prevention, early 
detection, and treatment and care within the 
primary health care sector. Specific questions 
focused on the existence of guidelines or 
protocols to treat major NCDs and the availability 
of the tests, procedures and equipment related to 
NCDs within the health system.
The survey included a set of detailed instructions on 
how to complete the questionnaire and a glossary 
defining the terms used in the questionnaire. The 
questionnaire was translated into Spanish, French, 
and Russian to facilitate completion in all countries. 
Each country followed their own formal review 
process before submitting their response to WHO.
Response rate
In total, 177 Member States (91%) responded to 
the survey. The response rates by WHO region are 
shown in Table 1. The response rates of all WHO 
regions, with the exception of the African Region, 
were greater than 90%. (A complete list of Member 
States by region is given in Annex 1.)
   TABLE 1: 
Response rate by WHO region
Analysis
Data were downloaded directly from the web-based 
platform to an Excel-readable file. Data cleaning 
was performed by the WHO Secretariat to ensure 
consistency with responses within a question and 
its sub-questions. All statistical analyses, including 
analysis by WHO region and World Bank income 
groups (2015 groupings, see Annex 2), were carried 
out using STATA 13 software (Stata Corporation, 
18
2013). All data extraction, cleaning and analysis was 
performed at WHO headquarters.
For all analyses, the denominator used was the total 
number of responding countries, either overall or 
within the subgroup of interest (Table 1). To avoid 
fluctuating denominators, percentages reported were 
based on the positive responses from countries to 
the survey items. Non-positive responses (i.e. “No”, 
“Don’t know”, and items left unanswered) were treated 
equally. Trends in national capacity for NCDs were 
derived from comparing the results of the 2015 survey 
with those from the capacity surveys conducted in 
2013 and 2010 by WHO. For the comparison of 
To raise the priority accorded 
to the prevention and control of 
noncommunicable diseases in global, 
regional and national agendas and 
internationally agreed development 
goals, through strengthened 
international cooperation and 
advocacy.
To reduce modifiable risk factors 
for noncommunicable diseases 
and underlying social determinants 
through creation of health-promoting 
environments.
To promote and support national 
capacity for high-quality research and 
development for the prevention and 
control of noncommunicable diseases.
To strengthen national capacity, 
leadership, governance, multisectoral 
action and partnerships to accelerate 
country response for the prevention 
and control of noncommunicable 
diseases.
To strengthen and orient health 
systems to address the prevention 
and control of noncommunicable 
diseases and the underlying social 
determinants through people-centred 
primary health care and universal 
health coverage.
To monitor noncommunicable diseases 
and their determinants, and evaluate 
progress at national, regional and 
global levels.
   BOX 1: 
Key objectives of the second WHO Global NCD  
Action Plan 2013–2020
1
3
5
4
2
6
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survey responses across these three surveys, analyses 
were limited to the 160 Member States that completed 
all three surveys and were focused only on those 
questions which appeared in all three surveys.
The results were examined in relation to the objectives 
and key recommendations made to WHO Member 
States in the Global NCD Action Plan (Box 1) as well 
as the progress monitoring indicators adopted in 2015 
which will be used by the WHO Director-General 
to report to the UNGA by the end of 2017 on the 
progress achieved in the implementation of the four 
time-bound commitments included in the 2014 United 
Nations Outcome Document on NCDs (Box 2).
   BOX 2: 
Progress Monitoring Indicators to be used by the WHO Director-General to report to 
the UN General Assembly by the end of 2017 
BY 
2015
BY 
2015
Consider setting national 
NCD targets for 2025
Consider developing 
national multisectoral 
policies and plans to 
achieve the national 
targets by 2025
   Indicator 2: 
   Indicator 1:  
   Indicator 3: 
Member State has a functioning system for 
generating reliable cause-specific mortality data 
on a routine basis.
Member State has set time-bound targets and 
indicators based on WHO guidance.
Member State has a STEPS surveya or a 
comprehensive health examination survey every 5 
years.
   Indicator 4: 
Member State has an operational multisectoral 
national strategy/action plan that integrates the 
major NCDs and their shared risk factors.
Time-bound 
commitments
Indicators
20
   Indicator 7: 
Member State has implemented the following four 
measures to reduce unhealthy diets:
a. Adopted national policies to reduce population 
salt/sodium consumption;
b. Adopted national policies that limit saturated 
fatty acids and virtually eliminate industrially 
produced trans-fatty acids in the food supply;
c. WHO set of recommendations on marketing of 
foods and non-alcoholic beverages to children;
d. Legislation/regulations fully implementing the 
International Code of Marketing of Breast-milk 
Substitutes.
   Indicator 5: 
   Indicator 6: 
Member State has implemented the following four 
demand-reduction measures of the WHO FCTCb at 
the highest level of achievement:
a. Reduce affordability of tobacco products by 
increasing tobacco excise taxes;
b. Create by law completely smoke-free 
environments in all indoor workplaces, public 
places and public transport;
c. Warn people of the dangers of tobacco and 
tobacco smoke through effective health warnings 
and mass media campaigns;
d. Ban all forms of tobacco advertising, promotion 
and sponsorship.
Member State has implemented, as appropriate 
according to national circumstances, the following 
three measures to reduce the harmful use of alcohol 
as per the WHO Global Strategy to Reduce the 
Harmful Use of Alcoholc:
a. Regulations over commercial and public 
availability of alcohol;
b. Comprehensive restrictions or bans on alcohol 
advertising and promotions;
c. Pricing policies such as excise tax increases on 
alcoholic beverages.
BY 
2016
Reduce risk factors for 
NCDs, building on 
guidance set out in the 
WHO Global NCD 
Action Plan
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a http://www.who.int/chp/steps/en/ 
b http://www.who.int/fctc/en/ 
c Global strategy to reduce the harmful effects of alcohol. World Health Organization, Geneva, 2010.
BY 
2016
Strengthen health systems 
to address NCDs through 
people-centred primary 
health care and universal 
health coverage, building 
on guidance set out 
in WHO Global NCD 
Action Plan
   Indicator 8: 
   Indicator 9: 
   Indicator 10: 
Member State has implemented at least one recent 
national public awareness programme on diet and/
or physical activity.
Member State has evidence-based national 
guidelines/protocols/standards for the 
management of major NCDs through a primary 
care approach, recognized/approved by 
government or competent authorities.
Member State has provision of drug therapy, 
including glycaemic control, and counselling 
for eligible persons at high risk to prevent 
heart attacks and strokes, with emphasis on the 
primary care level.
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Unit, branch or department responsible for NCDs
Ninety-three per cent of countries (93%) reported 
having a unit, branch or department in their ministry of 
health with responsibility for NCDs; 91% of countries 
reported having at least one full-time technical or 
professional staff member working within this unit, 
branch or department. As shown in Table 2, this 
includes 96% of low-income countries and 93% of 
lower-middle-income countries. 
ASPECTS OF NCD 
INFRASTRUCTURE
With NCD units/ 
branches/
departments
With full-time staff
WHO region
AFR 100 100
AMR 85 85
EMR 95 95
EUR 94 88
SEAR 91 91
WPR 88 88
World Bank
income Group
Low-income 96 96
Lower-middle-income 93 93
Upper-middle-income 88 88
High-income 95 89
ALL 93 91
   TABLE 2: 
Percentage of countries with units, branches or departments within the ministry of health (or 
equivalent) with responsibility for NCDs and percentage of these countries that have at least one 
full-time technical or professional staff member working in the unit, branch or department
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The availability of a national unit, branch or 
department responsible for NCDs within the ministry 
of health was already high in 2010 in all regions 
(88% overall) and showed further improvements 
between 2010 and 2013 (94%), with a slow 
decline occurring between 2013 and 2015 (93%). 
Over 90% of countries in the African Region, the 
Region of the Americas, the South-East Asia Region 
and the Western Pacific Region reported having an 
existing unit, branch or department in their ministry 
of health with responsibility for NCDs in 2010 (see 
Table 3).
2010 2013 2015
WHO 
Region
AFR 93 97 100
AMR 93 96 85
EMR 85 90 95
EUR 79 92 94
SEAR 100 100 90
WPR 92 96 88
ALL 88 94 93
   TABLE 3: 
Percentage of countries* with units, branches or departments within the ministry of health 
(or equivalent) with responsibility for NCDs by WHO region, 2010, 2013 and 2015
* of 160 countries that responded to all 3 surveys.
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Funding mechanisms
Countries were asked to report on the availability 
of funding for seven key risk factor activities or 
functions. Funding for health care and treatment was 
the most prevalent (94% of countries) with funding 
also prevalent for primary prevention of NCDs (88%), 
health promotion activities (87%), and early detection 
and screening (85%) (see Figure 1). The prevalence of 
funding for surveillance, monitoring and evaluation as 
well as for capacity-building reported by the countries 
was slightly lower overall, with only 81% of countries 
reporting funding for each of these. Palliative care 
funding was considerably less prevalent, with less than 
two thirds of countries (64%) reporting having funding. 
The African Region (40%), the Region of the Americas 
(44%) and the Eastern Mediterranean Region (50%) 
reported particularly low levels of funding for palliative 
care, while this area was more widely funded in the 
European Region (88%), the South-East Asia Region 
(82%) and the Western Pacific Region (76%). Countries 
of the South-East Asia Region reported 100% funding 
for all categories, with the exception of early detection 
(91%) and palliative care. 
2010 2013 2015
WHO 
Region
AFR 83 93 100
AMR 78 78 85
EMR 80 80 95
EUR 69 75 88
SEAR 100 90 90
WPR 84 92 88
ALL 79 83 91
   TABLE 4: 
Percentage of countries* with at least one full-time technical or professional staff member 
working in the unit, branch or department by WHO region, 2010, 2013 and 2015
* of 160 countries that responded to all 3 surveys.
The NCD staffing capacity also improved between 
2010 and 2015 (see Table 4). Seventy-nine per cent 
of countries (79%) reported in 2010 having at least 
one full-time technical or professional staff member 
working in the unit, branch or department responsible 
for NCDs within the health ministry, and this proportion 
increased to 83% in 2013 and 91% in 2015. With the 
exception of the South-East Asia Region, countries in all 
other regions reported an increase in the availability 
of full-time staff dedicated to NCDs. As shown in 
Table 4, these improvements were most notable in the 
European Region, the African Region and the Eastern 
Mediterranean Region, where the availability of full-
time technical or professional staff working in the NCD 
unit, branch or department within the ministry of health 
increased by at least 15%. 
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Trends in the funding for NCD activities between 
2010 and 2015 exist for two areas only: primary 
prevention and health promotion; and surveillance, 
monitoring and evaluation; both show mixed 
results. The availability of funding for primary NCD 
prevention and health promotion increased in all 
WHO regions between 2010 and 2013 with the 
exception of the Western Pacific Region (see Figure 
2). The most notable improvements were among 
countries in the Region of the Americas (from 78% in 
2010 to 96% in 2013), the Eastern Mediterranean 
Region (from 70% in 2010 to 85% in 2013), the 
South-East Asia Region (from 90% in 2010 to 100% 
in 2013) and the European Region (from 88% in 
2010 to 96% in 2013). However, between 2013 
and 2015, the funding available for primary NCD 
prevention and health promotion declined in all 
regions except for the African Region where it 
continued to increase gradually, and in the South-
East Asia Region where it remained at 100%. The 
most substantial declines in funding availability 
for primary prevention and health promotion were 
observed in the Eastern Mediterranean Region and 
Western Pacific Region with decreases to 65% and 
84% respectively in 2015.  
While availability of funding for NCD surveillance, 
monitoring and evaluation was generally lower than 
for primary NCD prevention and health promotion, 
funding increased steadily from 72% of countries in 
2010 to 78% in 2013, and to 82% in 2015 (see 
Figure 2). These positive trends were most notable 
among countries in the Region of the Americas, the 
South-East Asia Region and the African Region. 
The availability of funding for NCD surveillance, 
monitoring and evaluation was lowest in the Eastern 
Mediterranean Region, showing a decline from 55% 
in 2010 to 50% in both 2013 and 2015. 
Primary prevention
Health promotion
Early detection/screening
   FIGURE 1: 
Percentage of countries with funding for NCD activities by function, by WHO region
Health care and treatment 
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   FIGURE 2:
Percentage of countries* with funding of NCD-related activities, by WHO region, 2010, 
2013 and 2015
a) For primary prevention and health promotion
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* of 160 countries that responded to all 3 surveys.
* of 160 countries that responded to all 3 surveys.
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In decreasing order of prevalence, the following 
are among the major sources of funding for NCDs: 
government revenues (94% of countries); international 
donors (64%); health insurance (62%); and earmarked 
taxes (34%) (see Table 5). As shown in Table 5, low-
income countries reported receiving less funding from 
all sources: approximately 77% of low-income countries 
received government revenues, compared with 97% of 
countries in other income groups; 15% received funds 
from health insurance relative to 69% in other income 
groups; and 8% received earmarked taxes compared with 
39% in other income groups. A smaller percentage of low-
income countries received international donations (77%) 
compared with lower-middle-income countries (87%).
Thirty-four per cent (34%) of countries reported using 
earmarked taxes to fund NCDs; this was significantly 
lower in low-income countries relative to middle- and 
high-income countries. Health insurance was reported 
as being a funding source for only 15% of low-income 
countries which is considerably lower than for middle- 
and high-income countries, the majority of which 
reported health insurance as a major source of funding. 
The use of government revenues as a major source 
of funding for NCDs increased from 86% in 2010 to 
93% in 2013 and remained high at 94% in 2015 (see 
Figure 3a). Increases were most notable in the Region 
of the Americas (from 89% in 2010 to 100% in 2013 
and 2015) and the African Region (from 73% in 2010 
to 80% in 2013, and 83% in 2015). The use of health 
insurance funds to support NCD-related activities 
increased from 42% of countries identifying this as 
a major source of NCD funding in 2010, to 54% in 
2013 and 61% in 2015 (see Figure 3b). Countries 
in the African Region, the Region of the Americas, the 
   TABLE 5: 
Major funding sources for NCDs
FUNDING SOURCES FOR NCDS 
(Percentage of countries with funding source)
General 
government 
revenues
Health 
insurance
International 
donors
Earmarked 
taxes on 
alcohol, 
tobacco, etc.
Other
WHO 
region
AFR 86 31 86 20 17
AMR 97 85 76 50 32
EMR 90 60 55 15 15
EUR 98 75 35 33 21
SEAR 100 45 91 36 9
WPR 96 52 76 52 24
World 
Bank 
income 
group
Low-income 77 15 77 8 15
Lower-middle-
income 93 53 87 33 20
Upper-middle-
income 100 82 78 50 16
High-income 98 71 29 34 30
ALL 94 62 64 34 21
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European Region and the Western Pacific Region saw 
the greatest increases in the use of health insurance as 
a source of NCD funding. The reliance on international 
donors for funding NCD prevention and control 
activities increased marginally overall (from 56% in 
2010 to 63% in 2015). These increases were most 
notable among countries in the Region of the Americas 
and the African Region (see Figure 3c). Countries in 
the European Region showed a slight reduction in 
their reliance on international donors for funding NCD 
activities (from 42% in 2010 and 48% in 2013, to 
29% in 2015). Finally, although available in only one 
third of the countries, the use of earmarked taxes as 
a source of funding to support NCD prevention and 
control increased to 34% in 2015 compared with 23% 
in 2010 (see Figure 3d). Countries in the Region of the 
Americas and the Western Pacific Region reported the 
largest increases in the use of earmarked taxes to fund 
NCD prevention and control activities (from 15% to 
52% and 24% to 52%, respectively).
2010
2010
2013
2013
2015
2015
   FIGURE 3: 
Percentage of countries* ranking each of the following sources of funding in the top three 
major funding sources for NCDs, by WHO region, 2010, 2013 and 2015
a) General government revenues
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* of 160 countries that responded to all 3 surveys.
* of 160 countries that responded to all 3 surveys.
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* of 160 countries that responded to all 3 surveys.
* of 160 countries that responded to all 3 surveys.
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Fiscal interventions
Eighty-seven per cent (87%) of countries indicated they 
had implemented taxation on tobacco (excise and non-
excise taxes), with the highest prevalence of tobacco 
taxation in the European Region (96% of countries) 
followed by the Western Pacific Region (92% of 
countries) and the Region of the Americas (91% of 
countries). Alcohol taxation was the second most 
widespread fiscal intervention with 80% of countries 
reporting this type of intervention. Ninety-eight 
per cent (98%) of countries in the European Region 
reported taxation on alcohol compared with only 63% 
of countries in the African Region (see Figure 4a).
Sugar-sweetened beverages (18%) and foods high 
in fat, sugar or salt (8%) were far less likely to be 
taxed globally, based on the reporting provided. 
Conversely, as shown in Figure 4b, price subsidies 
for healthy foods and taxation incentives to promote 
physical activity were relatively low globally. Twenty-
one per cent (21%) of countries in the Region of the 
Americas subsidized healthy foods compared with 
10% or less of countries in other regions. Taxation 
incentives to promote physical activity were even less 
widespread with only 7% of countries engaging in 
this type of fiscal intervention. 
2010
2010
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c) International donors
d) Earmarked taxes on alcohol, tobacco, etc.
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As demonstrated in Figure 5, the majority of funds 
generated through the above fiscal interventions 
were primarily used by countries towards 
general revenue (71%). A far smaller percentage 
of countries reported that the generated funds 
were primarily used for general health and health 
services (12%) or for influencing health behaviours 
(4%).
Subsidies for healthy foods Incentives to promote physical activity
   FIGURE 4: 
Percentage of countries implementing fiscal interventions by category, by WHO region
a) Taxation on products
b) Subsidies and incentives
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Multisectoral commissions, agencies, or mechanisms
Sixty-three per cent (63%) of countries reported 
having a national multisectoral commission, agency, 
or mechanism to oversee NCD engagement, policy 
coherence and accountability of sectors beyond health. 
Thirty-four per cent (34%) of countries confirmed that their 
commission, agency, or mechanism was operational; 
while 24% indicated it was under development and 
5% reported that it was not in effect. Operational 
multisectoral commissions were most prevalent in the 
Western Pacific Region (48% of countries) and the 
European Region (44%), compared with 17% only of 
countries in the African Region (Figure 6).
   FIGURE 5: 
Percentage of countries by type of fund usage generated from fiscal interventions, 
by WHO region
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   FIGURE 6: 
Percentage of countries with a national multisectoral commission, agency or mechanism to 
oversee NCD engagement, policy coherence and accountability of sectors beyond health and 
the stage of implementation, by WHO region
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National health plans
Ninety-two per cent (92%) of countries reported 
including NCDs in their national health plan, with both 
the South-East Asia Region and the Western Pacific 
Region reporting 100% of countries. Of the reporting 
countries, 64% had included NCDs in their national 
development agenda, 77% of countries reported having 
a set of NCD indicators, and 60% a set of time-bound 
national targets for these indicators (see Figure 7).  
PLANS, POLICIES  
AND STRATEGIES
   FIGURE 7: 
Percentage of countries with NCDs in their national health plan, with NCDs in their 
national development agenda, with a set of national NCD indicators, and with a set of 
time-bound national targets for these indicators, by WHO region
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Policies addressing the major NCDs and/or their risk factors
While 86% of countries reported having a national 
policy, strategy or action plan that integrated several 
NCDs and their risk factors, only 62% of countries 
reported having an operational integrated plan. 
A further reduction was observed in multisectoral, 
integrated NCD plans (53% of countries). NCD 
Progress Monitoring Indicator 4 refers specifically to 
the existence of multisectoral integrated NCD policies, 
strategies or action plans. In order to be considered 
as having fully achieved this indicator, a country 
not only had to have an operational, multisectoral 
integrated NCD policy, strategy or action plan, but 
also had to indicate that this policy, strategy or action 
plan covered the four main NCDs (cardiovascular 
disease, diabetes, cancer, chronic respiratory 
disease) and the four main risk factors (tobacco use, 
unhealthy diet, physical inactivity, harmful use of 
alcohol1). Forty-one per cent (41%) of countries had 
fully achieved this indicator. The rate of achievement 
was highest in the Region of the Americas, with 50% 
of countries achieving the indicator, followed by 
44% of countries in the European Region. Between 
30–40% of countries achieved the indicator in the 
remaining regions (Figure 8).  
   FIGURE 8: 
Percentage of countries with a national NCD policy, strategy or action plan which integrates 
several NCDs and their risk factors and their level of plan integration, by WHO region
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Operational integrated multisectoral plan
Operational integrated multisectoral plan that covers the 4 main risk factors and 4 main conditions
1 Exception made for alcohol according to national context.
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Trends in the availability of an operational integrated 
national policy, strategy or action plan were very 
encouraging, with an overall increase from 33% 
in 2010 to 63% in 2015 (see Figure 9). The most 
striking increase was observed among countries in 
the African Region, with 73% of countries reporting 
having an operational integrated NCD policy, 
strategy or action plan in 2015, compared with 
17% in 2010 and 37% in 2013. Improvements 
were also substantial among countries in the 
Region of the Americas where national integrated 
policies, strategies or action plans increased more 
than two-fold during the five-year period (30% 
in 2010 compared with 63% in 2015). A similar 
improvement was seen in the European Region with 
63% of countries having operational integrated 
NCD policies, strategies or action plans in 2015 
compared with 31% in 2010.
2010
* of 160 countries that responded to all 3 surveys.
2013 2015
   FIGURE 9: 
Percentage of countries* with an operational integrated national NCD policy, strategy or 
action plan, by WHO region, 2010, 2013 and 2015
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Table 6 shows the overall percentage of countries 
with a policy, strategy or action plan for each NCD 
or risk factor. The figures represent the percentage of 
countries that either included an NCD or risk factor 
in their integrated policy, strategy or action plan, or 
had a specific policy, strategy or action plan for an 
NCD or risk factor. 
The majority of countries had a policy, strategy or 
action plan for all NCDs and their risk factors with 
the exception of overweight and obesity (44% of 
countries). With policies, strategies or action plans 
that were operational, the majority of countries 
addressed all main NCDs and risk factors, with the 
exception of overweight and obesity (31%). Tobacco 
use was the most widely addressed risk factor, with 
80% of countries reporting an operational policy, 
strategy or action plan. Physical inactivity, unhealthy 
diet, cardiovascular disease, diabetes, cancer/
cancer types, and harmful use of alcohol were each 
addressed by operational policies, strategies or 
action plans in approximately two thirds (67–72%) 
of countries and chronic respiratory disease in 58% 
of countries.
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Among all WHO regions, the majority of 
countries reported having an operational policy, 
strategy or action plan for the leading NCDs with 
the exception of the Eastern Mediterranean 
Region, where 35% of countries had operational 
policies on chronic respiratory diseases and only 
45% had operational cancer policies. Chronic 
respiratory diseases were the least likely to be 
addressed by an operational plan in all regions 
except the South-East Asia Region, where 
operational cancer plans were the least prevalent 
(55% of countries). Among all World Bank income 
groups, countries in the lower-middle-income 
group were least likely to have operational plans 
for each of the major NCDs; the exception to this 
was cancer for which operational plans were least 
widespread among upper-middle-income countries 
(Figure 10a).
Operational policies to address the main NCD risk 
factors were generally least widespread among 
countries in the Eastern Mediterranean Region. 
Operational policies addressing overweight and 
obesity were by far the least prevalent in the 
majority of WHO regions and World Bank income 
groups, reaching a high of 58% of countries in the 
European Region and 59% of high-income countries 
(Figure 10b).
   TABLE 6: 
Percentage of countries with a policy, plan or strategy addressing the major NCDs and/
or their risk factors
% of countries with 
a policy, strategy or 
action plan
% of countries with 
an operational policy, 
strategy or action plan
Tobacco use 94 80
Physical inactivity 91 70
Unhealthy diet 90 72
Cardiovascular disease 88 68
Diabetes 88 72
Cancer or particular cancer types 87 68
Harmful use of alcohol 86 67
Chronic respiratory disease 76 58
Overweight and obesity 44 31
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   FIGURE 10: 
Percentage of countries with operational plans, strategies or action plans for the leading 
NCDs and risk factors, by WHO region and World Bank income group
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The trends in the availability of operational policies, 
strategies or action plans addressing the four major 
NCDs are shown in Figure 11. Between 2010 and 
2015, the availability of an operational plan, policy 
or strategy increased rapidly for each of the four 
major NCDs. During this time, the percentage of 
countries that reported having an operational plan 
increased three-fold for chronic respiratory diseases 
(19% in 2010 compared with 58% in 2015) and 
almost two-fold for cardiovascular diseases (36% 
in 2010 compared with 69% in 2015). Seventy-
three per cent (73%) of countries reported having 
an operational plan addressing diabetes in 2015, 
compared with 46% in 2010 and 71% of countries 
reported having an operational plan addressing 
cancer in 2015, compared with 50% in 2010. This 
pattern of considerable progress is evident in the 
majority of WHO regions over the years, with the 
largest improvements being made in the African 
Region and the Region of the Americas. 
2010
2010
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2015
   FIGURE 11: 
Percentage of countries* with operational plans, policies or strategies or action plans for the 
four main NCDs, by WHO region, 2010, 2013 and 2015
a) Cardiovascular diseases
b) Cancers
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The trends in the availability of operational plans 
policies, strategies or action plans addressing 
each of the four main NCD risk factors (Figure 12) 
were similarly positive. The percentage of countries 
reporting having an operational plan nearly 
doubled for each risk factor from 2010 to 2015: 
36% of countries in 2010 to 66% of countries in 
2015 for reducing the harmful use of alcohol; 44% 
to 71% for reducing physical inactivity, 53% to 81% 
for decreasing tobacco use, and 44% to 73% for 
reducing unhealthy diet. Countries in the African 
Region improved the availability of an operational 
policy, plan or strategy targeting the four main 
risk factors in 2015 as much as three- or four-fold 
compared with 2010. Countries in the Region of 
the Americas, in the same timeframe, doubled their 
operational policies, plans or strategies targeting 
each of the four key NCD risk factors.
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   FIGURE 12: 
Percentage of countries* with operational plans, policies or strategies or action plans for the 
main NCD risk factors, by WHO region, 2010, 2013 and 2015 
a) Reducing the harmful use of alcohol
b) Reducing physical inactivity
%
 o
f 
co
un
tr
ie
s
%
 o
f 
co
un
tr
ie
s
AFR
AFR
AMR
AMR
EMR
EMR
EUR
EUR
SEAR
SEAR
WPR
WPR
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42
100
80
60
40
20
0
100
80
60
40
20
0
2010
2010
2013
2013
2015
2015
c) Decreasing tobacco use
d) Reducing unhealthy diet related to NCD 
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Research policy or plan 
Thirty-five per cent (35%) of countries had an 
NCD-related research policy in place, which could 
include community-based research and evaluation 
of the impact of interventions and policies. 
However, only 24% of countries indicated this was 
an operational research policy. Figure 13 shows 
that the proportion of countries with even a draft 
research policy was lowest in the African Region 
(20%) and among low- and lower-middle-income 
countries (23% and 18%, respectively). Operational 
policies were most widely available in the Eastern 
Mediterranean Region (35%) and European Region 
(31%) and were more than twice as likely to be 
available in upper-middle- (28%) and high-income 
(34%) countries than in low- (15%) and lower-
middle-income (11%) countries. 
Marketing to children
Twenty-eight per cent (28%) of countries reported 
having a policy to reduce the impact on children of 
the marketing of foods and non-alcoholic beverages 
high in saturated fats, trans-fatty acids, free sugars, or 
salt. Of the reporting countries, 54% in the European 
Region confirmed they had a marketing policy in 
place, as opposed to 6% in the African Region. The 
remaining regions reported policies existing in 18–28% 
of countries. When reviewing the data by World Bank 
income groups, a clear pattern emerged of an increasing 
prevalence of marketing policies corresponding to a 
rise in income group. While only slightly more countries 
reported voluntary/self-regulating policies compared 
with government-legislated policies (25 countries versus 
24 countries), government-legislated policies were 
significantly more widespread in all regions and income 
groups except in the European and Western Pacific 
Region and the high-income group. 
   FIGURE 13: 
Percentage of countries with an NCD-related research policy, by WHO region and World 
Bank income group
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Food regulation and policy
Twenty-seven per cent (27%) of countries reported 
having implemented policies to limit saturated fatty 
acids and eliminate industrial produced trans fats 
(i.e. partially hydrogenated vegetable oils) in the 
food supply. The European Region reported 50% of 
countries with a policy in place, with exactly half 
having voluntary/self-regulating policies and half 
having government legislated policies. The South-
East Asia Region reported 9% of countries with a 
government legislated policy in place; the African 
Region reported 3% of countries having a policy that 
was exclusively government legislated. The remaining 
regions reported having 20–26% of countries with 
an existing policy; government legislated policies 
were more prevalent in all regions except for the 
Western Pacific Region. The highest rate of policy 
implementation was reported in high-income 
countries at 57%, with 30% having government 
legislated policies. No low-income countries and 
only four lower-middle-income countries reported 
implementation of policies limiting saturated fatty 
acids (Figure 15).
   FIGURE 14: 
Percentage of countries with a policy to reduce the impact on children of the marketing of 
foods and non-alcoholic beverages high in saturated fats, trans-fatty acids, free sugars, or 
salt, and the method of regulation, by WHO region and World Bank income group
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Globally, 38% of countries reported implementing 
a policy to reduce population salt consumption. The 
European Region reported the highest number of 
countries at 62%, followed by the Western Pacific 
Region at 52%. The South-East Asia Region and the 
African Region reported 9% and 3% of countries, 
respectively. No low-income countries had implemented 
policies to reduce population salt consumption and 
prevalence of these policies was very low (13%) in lower-
middle-income countries. Just over 70% of high-income 
countries had implemented salt reduction policies and 
the majority (32 of 40 countries with policies) had 
voluntary/self-regulatory policies (Figure 16).
Thirty-five per cent (35%) of countries reported that their 
salt policy was intended to target public awareness, 
30% were targeting product reformulation, and 22% 
were targeting regulation of salt content in food. 
Countries could indicate that their salt policies targeted 
any number of these areas. With the exception of 
the African Region and the South-East Asia Region, 
where all policies targeted all three of these actions, 
the majority of policies in the remaining regions and 
income groups targeted public awareness. Policies 
that targeted the reduction of salt content in food were 
consistently the least widespread, except in middle-
income countries (Figure 17). 
   FIGURE 15: 
Percentage of countries with a policy to limit saturated fatty acids and eliminate industrially 
produced trans fats in the food supply and the method of regulation, by WHO region and 
World Bank income group
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   FIGURE 16: 
Percentage of countries with any policy to reduce population salt consumption and the 
method of regulation, by WHO region and World Bank income group
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   FIGURE 17: 
Percentage of countries with salt policies targeting product reformulation, salt content regulation 
or public awareness programmes, by WHO region and World Bank income group
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Sixty-eight per cent (68%) of countries reported having 
implemented a national public awareness programme 
on diet and 63% a programme on physical activity, both 
within the past five years. Countries from the South-East 
Asia Region reported a 100% implementation rate for 
national public awareness programmes for diet, and a 
91% implementation rate on programmes for physical 
activity, the highest for both topics for any region. 
Public awareness programmes were the least prevalent 
in the African and Eastern Mediterranean Regions, 
with only 43% for diet and 37% for physical activity in 
Africa and 45% for diet and 50% for physical activity 
in the Eastern Mediterranean. Reported programme 
implementation ascends with income level for both 
types of awareness programmes (Figure 18).
Fifty-eight per cent (58%) of countries had implemented 
a programme on nutrition labelling, in line with 
international standards for pre-packaged foods – 
particularly those set by the Codex Alimentarius1 – 
with rates ranging from 36% only of countries in the 
South-East Asia Region to 83% in the European Region 
and 38% in low- and lower-middle-income countries 
to 79% in high-income countries (Figure 19).
   FIGURE 18: 
Percentage of countries with an implemented public awareness programme that addressed 
diet or physical activity, by WHO region and by World Bank income group 
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1 http://www.fao.org/fao-who-codexalimentarius/en/
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   FIGURE 19: 
Percentage of countries with nutrition labelling regulations in line with international standards, 
by WHO region and by World Bank income group
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Surveillance responsibility
Twenty-three per cent (23%) of countries reported having 
a dedicated office, department, or administrative division 
within their ministry of health exclusively dedicated to 
NCD surveillance. Countries of the South-East Asia Region 
reported 45% having a dedicated surveillance team – the 
highest reported of all regions; the Region of the Americas, 
with 15% of countries, reported the lowest. However 56% 
of countries in this region reported a team within the 
ministry of health responsible for surveillance although not 
exclusively dedicated to NCDs. The second highest region 
with a team responsible for, but not dedicated to, NCD 
surveillance within the ministry of health was the African 
Region with 54% of countries. Countries in the European, 
South-East Asia, and Western Pacific Regions reported 
that 52%, 36% and 48% of countries, respectively, had 
responsibility for surveillance shared among several 
offices, departments and administrative divisions within 
the ministry of health. This structure was most prevalent in 
high-income countries (52%) and least prevalent in low-
income countries (19%). Globally, two countries only, both 
in the Eastern Mediterranean Region, reported no one 
having responsibility for NCD surveillance.
SURVEILLANCE
   FIGURE 20: 
Percentage of countries with an area of responsibility for the surveillance of NCDs and their risk 
factors, by WHO region and World Bank income group
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Civil and vital registration systems reporting mortality by cause
Eighty-eight per cent (88%) of countries reported 
having a system for collecting mortality data by cause 
of death on a routine basis, with 100% of high-income 
and 98% of upper-middle-income countries reporting 
such a registration system. One hundred per cent 
(100%) of countries in the Region of the Americas 
and the European Region had such a system and all 
further specified having a civil/vital registration system 
in place. Only 25% of countries indicated they had a 
sample registration system for reporting cause of deaths, 
with these types of systems being most prevalent in 
lower-middle-income countries (38%) and the Western 
Pacific Region (52%) (Figure 21). Only two countries 
reported having only a sample registration system in 
place; all other countries reported also having a vital 
registration system in place.
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   FIGURE 21: 
Percentage of countries with a system for collecting mortality data by cause of death and the 
type of registration system, by WHO region and World Bank income group
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Cancer registries
Most countries (84%) reported having a cancer 
registry, although considerably fewer (59%) had a 
population-based cancer registry. Population-based 
cancer registries were most prevalent in the European 
Region (71%) and were available in at least 50% 
of countries in all other regions except the South-
East Asia Region (45%). While 86% of high-income 
countries had population-based cancer-registries, the 
availability of population-based registries declined 
with declining income group.
   FIGURE 22: 
Percentage of countries with cancer registries, by WHO region and World Bank income group
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The percentage of countries with a cancer registry 
was already high in 2010 (81%); nevertheless 
this increased to 88% in 2015. The existence of 
a population-based cancer registry saw an even 
greater improvement, from 47% to 63% during the 
five-year period 2010–2015. All regions observed 
improvements in the availability of population-based 
cancer registries from 2010. The most noticeable 
was in the African Region, with more than twice 
the number of countries in 2015, compared with 
2010, reporting having population-based cancer 
registries.
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   FIGURE 23: 
Percentage of countries* with population-based cancer registries by WHO region, 2010, 
2013 and 2015 
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Diabetes registries
Forty-four per cent (44%) of countries reported 
having a diabetes registry, and 14% a population-
based registry. The Western Pacific Region reported 
the highest percentage of countries with a diabetes 
registry (72%) followed by the European Region 
(58%). However, more countries in the European 
Region reported having population-based diabetes 
registries than in the Western Pacific Region (29% 
compared with 20%). Countries from the African 
Region reported the lowest numbers, with 17% having 
a diabetes registry, and none having population-
based registries. Similarly, the low-income group of 
countries reported 19% with registries and none with 
population-based registries. Just over half of countries 
in the upper-middle and high-income groups reported 
having a diabetes registry, with 18% of countries 
in these income groups having a population-based 
registry (Figure 24).
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Risk factor surveys
Almost a quarter of countries (24%) had not conducted 
any recent (i.e. in 2010 or later) national adult risk 
factor surveys, with a further 14% of countries only 
conducting recent, national adult surveys for 1–4 
of the main 9 NCD risk factors (harmful alcohol 
use, low fruit and vegetable consumption, physical 
inactivity, tobacco use, overweight and obesity, 
raised blood pressure, raised blood glucose, 
raised cholesterol, and sodium intake). Surveillance 
activities were inconsistent among regions with 50% 
or more countries in the Region of the Americas, the 
European Region, the South-East Asia Region and the 
Western Pacific Region all reporting recent, national 
adult risk factor surveys covering 8 or 9 risk factors. 
In the African Region, where nearly 50% of countries 
carried out no recent, national adult risk factor 
surveys, 31% only covered 8 or 9 risk factors and in 
the Eastern Mediterranean Region, 15% only. When 
considering the data by country income group, a 
sharp decline was observed with increasing income 
from 50% of low-income countries having carried out 
no recent, national adult risk factor surveys to 7% 
of high-income countries. Only among countries in 
the high-income group had the majority conducted 
recent, national surveys for all, or nearly all, of the 
main 9 risk factors (Figure 25).
   FIGURE 24: 
Percentage of countries with a diabetes registry, by WHO region and World Bank income group
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   FIGURE 25: 
Percentage of countries covering 0–9 risk factors in recent, national adult NCD risk factor surveys
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The situation was similar for adolescent risk factor 
surveillance activities, for which 5 risk factors were 
considered (harmful alcohol use, low fruit and 
vegetable consumption, physical inactivity, tobacco 
use and overweight and obesity). Twenty-four per 
cent (24%) of countries reported conducting no 
recent, national adolescent risk factor surveys. 
Just over half (52%) covered 4 or 5 risk factors 
in recent, national surveys. Adolescent risk factor 
surveillance was also inconsistent among regions 
   FIGURE 26: 
Percentage of countries covering 0–5 risk factors in recent, national adolescent NCD risk 
factor surveys
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and country income groups. Most countries in the 
European Region (71%) and Western Pacific Region 
(68%) covered 4 or 5 of the main risk factors in 
recent, national surveys, as had 56% of countries in 
the Region of the Americas. Adolescent risk factor 
surveillance was weakest in the African Region, 
with 20% only of countries covering 4 or 5 risk 
factors in recent, national surveys. Much progress 
remains to be made in the Eastern Mediterranean 
and South-East Asia Regions, where only 36% and 
40% of countries, respectively, covered 4 or 5 
risk factors. As with adult risk factor surveillance, 
there was a clear trend in increasing adolescent 
risk factor surveillance activity corresponding with 
increased country income group, with 27% only of 
low-income countries covering 4 or 5 risk factors in 
recent, nation surveys compared with 77% of high-
income countries (Figure 26).
When considering surveillance activity by risk 
factor, surveillance of tobacco use was the most 
widespread, with 69% of countries reporting having 
collected recent, national data among adults, and 
71% reporting having collected recent, national data 
among adolescents. Surveillance of salt/sodium intake 
was the weakest, with 34% only of countries reporting 
surveillance of this risk factor. Recent, national data on 
the remaining behavioural risk factors were collected 
in around 60% of countries for adults and just over 
50% of countries for adolescents, while data on the 
remaining biochemical risk factors were collected on 
adults in just over 50% of countries (Figure 27). 
   FIGURE 27: 
Percentage of countries that have conducted recent, national adult or adolescent risk factor 
surveys, by risk factor 
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The set of ten NCD progress monitoring indicators 
(see Box 2) included an indicator questioning whether 
each Member State conducted a STEPS survey or a 
comprehensive health examination survey every five 
years. To attain full achievement of this indicator, a 
country had to indicate that they had conducted a 
recent survey (i.e. within the past five years – thus 
2010 or later) of adults on all NCD risk factors – 
except raised total cholesterol and low fruit and 
vegetable consumption – and that they conducted the 
survey regularly (i.e. that they responded “every 1 to 
2 years” or “every 3 to 5 years” to the question on the 
frequency of the survey for each risk factor). Only 20% 
of countries fully achieved this indicator. Over a third 
of countries (36%) in the Western Pacific Region and 
just under a third of countries (29%) in the Region of 
the Americas fully achieved this indicator. The Eastern 
Mediterranean Region was lowest with one country 
alone (5%) achieving the indicator. High-income 
countries, with 34%, had the highest rate, and in the 
low- and middle-income groups, between 10% and 
20% countries attained full achievement (Figure 28).
Since 2010, there has been a rise in the number of 
countries implementing recent (i.e. in the five years 
leading up to each round of the Country Capacity 
Survey), national surveys for each of the major NCD 
risk factors. Overall, the greatest progress was seen in 
surveys covering low fruit and vegetable consumption 
(51% of countries in 2010 compared with 73% in 
2015), followed by surveys covering harmful alcohol 
use, overweight and obesity, and physical inactivity. 
Progress in the surveillance of salt and sodium intake 
can only be compared between 2013 and 2015, 
since this risk factor was not covered in the 2010 
survey. However, in this limited period of time, 
2013–2015, surveillance of this risk factor increased 
by approximately 25% (27% of countries in 2013 
compared with 34% in 2015) (Figure 29).
   FIGURE 28: 
Percentage of countries that have fully attained Progress Monitoring Indicator number 3, on 
regular health examination surveys, by WHO region and World Bank income group
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   FIGURE 29: 
Percentage of countries* that have conducted recent, national risk factor surveys, 2010, 
2013 and 2015
%
 o
f 
co
un
tr
ie
s
Tobacco 
use
Raised blood 
glucose/
diabetes
Overweight 
and obesity
Raised total 
cholesterol
Low fruit and 
vegetable 
consumption
Salt/sodium 
intake
Physical 
inactivity
Raised blood 
pressure/
hypertension
2010 2013 2015
Harmful 
alcohol use
* of 160 countries that responded to all 3 surveys.
60
100
80
60
40
20
0
NCD-related guidelines and referral criteria
Countries were asked if they had evidenced-based 
national guidelines/protocols/standards available for 
the management of each of the major NCDs through 
a primary care approach recognized or approved by 
government or competent authorities. Where guidelines 
existed, countries were asked to further specify if the 
guideline(s) were fully or partially implemented, or not 
implemented at all. Guidelines for diabetes were the 
most widely available with 75% of countries reporting 
having guidelines. Guidelines for cardiovascular 
diseases were the second most prevalent (available in 
67% of countries), followed by guidelines for cancer 
(available in 60% of countries). Just over half of countries 
(55%) reported having guidelines for chronic respiratory 
diseases. Most countries had guidelines fully or partially 
implemented, with 90% or more of countries having 
fully or partially implemented guidelines available for 
each NCD (Figure 30).
HEALTH  
SYSTEMS CAPACITY
   FIGURE 30: 
Percentage of countries that have evidenced-based national guidelines/protocols/standards 
for the management of each of the main NCDs and whether the standard guidelines/
protocols/standards are fully or partially implemented
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An indicator on the availability of evidence-based 
national guidelines for the four main NCDs was 
included in the NCD progress monitoring indicators. 
In order to achieve this indicator, a country needed to 
have guidelines available for all four key NCDs and all 
had to be either fully or partially implemented. Thirty-
seven per cent (37%) of countries met this indicator fully, 
with achievement highest in the European Region (52%) 
and among high-income countries (46%). Less than 
one in five of countries (19%) in the low-income group 
achieved the indicator, and achievement was similarly 
low in the Region of the Americas (21%) (Figure 31).
   FIGURE 31: 
Percentage of countries with guidelines that are partially or fully implemented for all four 
main NCDs (Progress Monitoring Indicator number 9), by WHO region and World Bank 
income group 
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Countries were asked to indicate the availability of 
standard criteria for the referral of patients from primary 
care level to a higher level of care for each of the four 
main NCDs, and whether these criteria were fully or 
partially implemented. The majority of countries had 
criteria in place for each NCD, with diabetes criteria 
most prevalent (73% of countries), followed closely by 
criteria for cardiovascular diseases (68%) and cancer 
(64%). Criteria for chronic respiratory diseases were 
available in 57% only of countries. More than 90% 
of countries with criteria for each NCD indicated that 
these were fully or partially implemented (Figure 32).
Availability of tests and procedures for early detection,  
diagnosis and monitoring of NCDs
The majority of countries reported having some basic 
technologies generally available for early detection, 
diagnosis and monitoring of NCDs in primary care 
facilities in the public health sector: 97% for blood 
pressure measurement, 95% for weight measurement, 
and 90% for height measurement. Blood glucose 
measurement was also widely available, with 85% 
reporting general availability in primary care facilities 
in the public health sector. Approximately two thirds of 
countries reported general availability for urine strips 
for glucose and ketone measurement (67%), urine 
strips for albumin assay (64%) and total cholesterol 
measurement (59%). The oral glucose tolerance test 
was generally available in 51% only of countries 
and less than half of countries reported general 
availability for the remaining basic technologies: 
HbA1c test (47%), dilated fundus examination (45%), 
foot vibration perception by tuning fork (41%), 
peak flow measurement spirometry (37%), and foot 
vascular status by Doppler (28%).
   FIGURE 32: 
Percentage of countries with standard criteria for the referral of patients from primary care 
level to a higher level of care and with standard criteria fully or partially implemented
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The availability of a selection of basic technologies 
for early detection, diagnosis and monitoring of 
NCDs is shown in more detail in Figure 33. While 
height and weight and blood pressure measurements 
were widely available across all regions and income 
groups, the availability of HbA1c testing was highly 
variable, with 91% of high-income countries, but less 
than half of countries in the middle-income groups 
and a single low-income country reporting general 
availability. No countries in the South-East Asia Region 
and two countries only in the African Region reported 
HbA1c being widely available; however 50% or more 
countries reported its availability in the Region of the 
Americas (50%), the European Region (81%) and 
the Western Pacific Region (56%). Total cholesterol 
testing availability was also highly variable. While 
the majority of high-income countries (95%) reported 
total cholesterol testing being generally available, just 
over a third of lower-middle-income countries (36%) 
and only four low-income countries (15%) reported 
generally availability. No countries in the South-
East Asia Region had cholesterol testing generally 
available; however 23% of countries in the African 
Region, 35% of countries in the Eastern Mediterranean 
Region and 60% or more of countries in the remaining 
regions reported that testing was generally available. 
   FIGURE 33: 
Percentage of countries with availability of selected basic technologies for early detection, 
diagnosis, and monitoring of NCDs in the primary care facilities of the public and private 
health sector, by WHO region and World Bank income group
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Cancer Screening Programmes
Seventy-six per cent (76%) of countries reported having 
a breast cancer screening programme, including 95% 
of high-income countries and 50% of low-income 
countries. Breast cancer screening programmes were 
most prevalent in the European Region (92%) and the 
Region of the Americas (82%), while countries in the 
African Region (57%) and South-East Asia Region 
(64%) were least likely to have such programmes. 
Although more countries overall reported having 
organized, population-based screening programmes 
(41%) versus opportunistic programmes (34%), only 
the European Region (73%) and the high-income 
group (73%) reported a majority of countries with 
population-based screening programmes (Figure 
34a). Only 14% of countries reached 70% or more of 
the target population for the breast cancer screening 
programmes and a further 11% reached more than 
50% but less than 70% of the target population, thus 
the majority of programmes were reaching 50% or 
less of the target population (Figure 34b). 
   FIGURE 34: 
Percentage of countries with a breast cancer screening programme, the type of screening 
programme, and percentage of screening coverage, by WHO region and World Bank 
income group 
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Seventy-nine per cent (79%) of countries reported 
having cervical cancer screening programmes 
in place. While 45% of countries indicated that 
screening programmes were organized and 
population-based, 32% indicated that screenings 
were opportunistic. As demonstrated in Figure 35a, 
the increase in available cervical cancer screening 
corresponded to World Bank income group. The 
same was observed with screening programme type 
where rates of population-based screening generally 
increased in line with rising income group. Cervical 
cancer screening programmes were available in 
most countries in all regions with the exception of 
the Eastern Mediterranean Region, where only 25% 
of countries had such screening programmes, most 
of which (3 of 5 countries with programmes) were 
opportunistic (Figure 35a). Only 12% of countries 
had cervical cancer screening programmes reaching 
70% or more of the population; the European Region 
and the high-income group reported the highest 
number of countries with this rate of coverage. 
Globally, the most frequently reported (30% of 
countries overall) coverage level was 10–50%, 
which was also the most frequently reported among 
countries in the three highest income groups. The 
majority of screening programmes in low-income 
countries and the African Region reached less than 
10% of the target population (Figure 35b). 
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   FIGURE 35: 
Percentage of countries with a cervical cancer screening programme, the type of screening 
programme, and percentage of screening coverage, by WHO region and World Bank income 
group 
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Forty per cent (40%) of countries reported having a 
colon cancer screening programme in place, the 
majority of these (43 of 70 countries with programmes) 
being high-income countries. While 77% of high-
income countries reported having a cancer screening 
programme, 15% only of low-income countries had 
such screening programmes. With the exception of 
the European Region, with 71% of countries indicating 
having a colon cancer screening programme, less than 
a third of countries in all other regions reported having 
such programmes. Twenty-two per cent (22%) of 
countries had organized, population-based screening 
programmes, while 15% reported the programme 
was opportunistic. No low- and lower-middle-income 
countries, or countries in the South-East Asia Region, 
and only one country in the African Region reported 
having population-based screening programmes 
(Figure 36a). Coverage of programmes was low 
among all regions and income groups. High-income 
countries and countries in the European and Western-
Pacific Regions and the Region of the Americas 
reported that the colon cancer screening programme 
covered between 10–50% of the target population. In 
the African Region and Eastern Mediterranean Region, 
most available programmes covered less than 10% of 
the target population (Figure 36b).
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   FIGURE 36: 
Percentage of countries with a colon cancer screening programme, the type of screening 
programme, and percentage of screening coverage, by WHO region and World Bank income 
group
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Prostate screening existed in just under one third 
(29%) of countries, but was almost exclusively 
opportunistic in nature (45 of 51 countries with 
screening programmes). As shown in Figure 37a, 
very few countries reported organized, population-
based screening (3%). While coverage is not 
known for nearly a third of reported programmes, 
most programmes across all regions and income 
groups where the coverage is known covered less 
than 50% of the target population (Figure 37b).
   FIGURE 37: 
Percentage of countries with a prostate cancer screening programme, the type of screening 
programme, and percentage of screening coverage, by WHO region and World Bank 
income group 
%
 o
f 
co
un
tr
ie
s
%
 o
f 
co
un
tr
ie
s
AFR
AFR
Low- 
income
Low- 
income
AMR
AMR
Lower- 
middle- 
income 
Lower- 
middle- 
income 
EMR
EMR
Upper- 
middle 
income
Upper-
middle 
income
EUR
EUR
High-  
income
High-  
income
SEAR
SEAR
WPR
WPR
Organised, Population-based Opportunistic
a) Prostate cancer screening by type of screening
b) Colon cancer screening by screening coverage
<10%
10-50%
>50% but <70%
≥ 70%
Don’t Know
69Report of the 2015 Global NCD Survey
100
80
60
40
20
0
%
 o
f 
co
un
tr
ie
s
AFR Low- 
income
AMR Lower- 
middle- 
income 
EMR Upper- 
middle 
income
EUR High-  
income
SEAR WPR
b) Prostate cancer screening by screening coverage
HPV vaccination programmes
Just under half (49%) of all countries reported 
having a human papilloma virus (HPV) vaccination 
programme under implementation. Three-quarters 
(76%) of high-income countries reported having 
such a programme in place, with 29% having 
programmes covering more than 70% of the target 
population. In each of the other income groups, just 
over a third of countries had implemented an HPV 
vaccination programme. While among low-income 
countries, most of such programmes covered less 
than 10% of the target population, coverage was 
somewhat higher in middle-income countries. With 
the exception of the Eastern Mediterranean Region 
(10% only of countries) and South-East Asia Region 
(18% only of countries), at least 50% of countries in 
all other WHO regions reported implementing an 
HPV vaccination programme. Programme coverage 
was highest in the European Region with 23% of 
countries (12 of 31 countries with programmes) 
covering at least 70% of the target population; 
however, even in this region the majority of countries 
reported lower coverage (Figure 38).
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Availability of medicines in the public health sector
The survey assessed information on the availability of 
basic medicines required for the treatment of NCDs in the 
primary care facilities of the public health sector. Most 
essential medicines for the management of the leading 
NCDs were generally available in the majority of countries 
(Table 7). Aspirin (100 mg) and thiazide diuretics were 
the most readily available medicines (available in 88% 
of countries). Metformin was the second most available 
(available in 82% of countries), followed by ACE inhibitors 
(79%), Beta blockers (78%), bronchodilators (77%), and 
CC blockers (76%). Insulin was reported to be available 
in 72% of countries. Sulfonylurea(s) were less readily 
available with just over two thirds of countries (69%) 
reporting generally availability; however statins (63%) 
and steroid inhalers (59%) were even less common. The 
least available medicine was oral morphine (43%).
   FIGURE 38: 
Percentage of countries with a national HPV vaccination programme and the percentage of 
screening coverage, by WHO region and World Bank income group 
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Beta 
Blockers
Statins Oral 
morphine
Steroid 
inhaler
Broncho-
dilator
Sulphonyl-
urea(s)
WHO 
region
AFR 46 11 14 31 46 23
AMR 88 76 41 71 88 85
EMR 70 50 15 55 90 75
EUR 96 90 77 87 88 90
SEAR 73 55 18 0 73 36
WPR 80 72 48 56 72 80
World 
Bank
income 
group
Low-income 38 8 15 23 38 15
Lower-middle-income 67 40 13 31 73 67
Upper-middle-income 86 74 46 70 82 74
High-income 98 96 77 89 93 93
ALL 78 63 43 59 77 69
Insulin Aspirin 
(100 mg)
Metformin Thiazide 
Diuretics
ACE 
Inhibitors
CC 
Blockers
WHO 
region
AFR 40 71 51 66 49 46
AMR 91 94 94 94 91 88
EMR 70 80 85 90 75 75
EUR 92 98 92 98 96 96
SEAR 36 91 73 73 55 45
WPR 68 88 88 92 80 72
World 
Bank
income 
group
Low-income 23 69 42 65 35 31
Lower-middle-income 53 82 73 80 73 64
Upper-middle-income 88 92 94 94 86 86
High-income 96 98 96 98 96 96
ALL 72 88 82 88 79 76
   TABLE 7: 
Percentage of countries with medicines generally available in the public health sector, by 
WHO region and World Bank income group
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Procedures for treating NCDs
In the survey, countries were asked about the 
availability of a selection of procedures used for 
treating NCDs (Figure 39). The majority of countries 
(79% or more) in the high-income group reported 
all five listed treatments being generally available: 
retinal photocoagulation, renal replacement by 
dialysis, renal replacement by transplantation, 
coronary bypass or stenting, and thrombolytic 
therapy. Low-income countries reported availability 
of renal replacement dialysis in 27% of countries, 
while the remaining four treatments were available in 
4–12% only of low-income countries. Among the six 
WHO regions, treatments were generally and most 
widely available in the European Region (73–88% 
of countries) and Eastern Mediterranean Region (55–
80% of countries).
   FIGURE 39: 
Percentage of countries with procedures generally available for treating NCDs in the public 
health-care system, by WHO region and World Bank income group
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Cancer diagnosis and treatment
Sixty-seven per cent (67%) of countries reported 
that cancer centres or cancer departments at the 
tertiary level were generally available in the public 
sector. Pathology services were generally available 
in the public health sector in three-quarters (75%) of 
countries. Cancer surgery (69% of countries) and 
subsidized chemotherapy (63% of countries) were 
less widely available. A distinct decline in availability 
that corresponded to a decrease in income group 
was observed for all four diagnosis and treatment 
services. Countries in the European Region (92% or 
more of countries) and Eastern Mediterranean Region 
(80% or more of countries) were the most likely to 
provide these services, while they were less readily 
available in the African Region (31–37% of countries) 
(Figure 40).
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   FIGURE 40: 
Percentage of countries with generally available cancer diagnosis and treatment services in 
the public sector, by WHO region and World Bank income group
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Palliative care
In the survey, countries were asked about the 
availability of palliative care for patients with NCDs 
in the public health system – specifically in primary 
health care and in community or home-based care. 
Forty-one per cent (41%) responded that palliative 
care was available to at least 50% of NCD patients 
in need in primary health care and 36% in community 
or home-based care. Among all WHO regions, the 
European Region reported the highest availability 
of palliative care with 73% of countries in primary 
health care, and 69% in community or home-based 
care. The region with the second highest levels of 
palliative care, was the Western Pacific Region 
with 48% of countries offering palliative care in a 
primary health care setting, and 44% in a community 
or home-based care setting. Among the remaining 
four regions, palliative care in a primary health-
care setting was generally available in 10–29% of 
countries, and in a community or home-based care 
setting in 9–26% of countries. Availability of care 
increased with income group with 66% and 70% of 
high-income countries offering palliative care in a 
primary health-care setting and community or home-
based setting, respectively, while 19% only of low-
income countries offered palliative care to at least 
50% of NCD patients in need in the primary health-
care setting and 4% in community or home-based 
care (Figure 41).
   FIGURE 41: 
Percentage of countries with palliative care generally available to NCD patients in a primary 
health care setting or community or home-based care, by WHO region and World Bank 
income group
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Cardiovascular risk stratification
Twenty-one per cent (21%) of countries reported 
having more than 50% of primary health-care 
facilities offering cardiovascular risk stratification 
for the management of patients at high risk of heart 
attack and stroke; the highest responses came from 
high-income countries (41%) and the European 
Region (38%). Twenty-six per cent (26%) of countries 
reported having less than 25% of primary health-care 
facilities that offered cardiovascular risk stratification 
and 20% of countries offered no risk stratification. 
The low- and lower-middle-income countries reported 
high rates of limited cardiovascular risk stratification 
and among low-income countries, 42% offered no 
risk stratification at any primary health-care facilities 
and 35% reported having less than 25% of facilities 
offering risk stratification. A similar situation was 
observed in the African Region, where 40% of 
countries reported offering no risk stratification 
and 37% offered risk stratification in under 25% of 
primary health-care facilities (Figure 42).   
Care of acute stroke and rehabilitation
While 6% of countries reported that provision for care of 
acute stroke and rehabilitation was not available in any 
public sector health facilities, 24% reported that these 
services were available in over 50% of public sector 
health facilities and 50% reported them being available 
in 50% or less of public sector health facilities. Countries 
in the European and Eastern Mediterranean Regions 
and high-income countries reported the highest rates of 
wide availability (i.e. more than 50% of public health 
sector facilities) of acute stroke care and rehabilitation. 
Countries from the low-income, lower-middle-income, 
African Region and Region of the Americas groupings 
reported provision for stroke in less than 25% of public 
sector health facilities (Figure 43). 
   FIGURE 42: 
Percentage of primary health-care facilities offering cardiovascular risk stratification for the 
management of patients at high risk for heart attack and stroke, by WHO region and World 
Bank income group
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   FIGURE 43: 
Percentage of public sector health facilities with provision for care of acute stroke and 
rehabilitation, by WHO region and World Bank income group
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Secondary prevention of rheumatic fever and rheumatic heart disease
Thirty-four per cent (34%) of countries reported 
provision for secondary prevention of rheumatic fever 
and rheumatic heart disease in the majority of public 
health sector facilities, while 10% only of countries 
reported that no public health sector facilities had such 
provisions available. Forty-six per cent (46%) of high-
income countries reported having at least 50% of public 
sector health facilities with provision for secondary 
prevention of rheumatic fever and rheumatic heart 
disease; however 43% did not respond to the question, 
the highest unknown rate of all income groups. The 
situation was similar among countries in the European 
Region with 46% having at least 50% of health-care 
facilities with provision for secondary prevention of 
rheumatic fever and rheumatic heart disease, but 38% 
not responding to the question. Twenty-seven per cent 
(27%) of low-income countries had no provision at 
any public health sector facility, compared with 13% 
of lower-middle-income countries, and 4% for the two 
other income groups (Figure 44).  
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   FIGURE 44: 
Percentage of public sector health facilities with provision for secondary prevention of rheumatic 
fever and rheumatic heart disease, by WHO region and World Bank income group
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Infrastructure, governance and financing
The availability of NCD units with full-time staff was 
high – staffing, in particular, showed considerable 
improvement from 2010. However, funding for 
NCD activities, although available in most countries, 
remained inadequate. Funding for primary 
prevention, screening and health promotion lagged 
considerably behind funding for other areas, and 
funding for palliative care, surveillance and capacity-
building was even less widely available. Government 
revenues were the most widespread source of funding 
for NCDs among countries. They were also the most 
widely reported of the top three funding sources in all 
income groups and regions except among countries 
in the African Region and low-income countries, both 
of which reported that funding from international 
donors was equally prevalent. Although considerably 
more countries reported health insurance and 
earmarked taxes as a funding source for NCDs in 
2015 compared with 2010, these were still far less 
prevalent, especially in low-income countries and 
countries in the Region of the Americas and the 
Western Pacific Region. While tobacco and alcohol 
taxation was fairly widespread, other possible fiscal 
interventions, such as price subsidies for healthy foods 
or taxation of sugar-sweetened beverages, were rare. 
Multisectoral NCD commissions to oversee NCD 
engagement, policy coherence and accountability 
of sectors beyond health were operational in only a 
third of countries and under development in another 
quarter of countries.
Policies, action plans and strategies
NCDs have been widely adopted in national health plans 
(92% of countries) with 60% of countries having a set 
of time-bound national targets for their NCD indicators. 
Significant progress was made in the availability of 
operational integrated plans, with figures being almost 
double those of 2010. However, while 62% of countries 
reported having an operational integrated NCD plan, 
only 41% achieved NCD Progress Monitoring Indicator 
4 (see Box 2) in having an operational multisectoral 
integrated plan covering the four main NCDs and their 
risk factors. While 35% of countries reported having 
NCD-related research policies, only 24% reported 
such policies being operational, the prevalence being 
notably low in low-income (15%) and lower-middle-
income (11%) countries. Implementation of cost-effective 
policies for NCDs related to diet was relatively low with 
approximately a third or less of countries overall, and 
almost no low-income countries, implementing a policy.
NCD surveillance
The majority of countries reported having an office, or 
offices, within their ministry of health with responsibility 
for NCD surveillance. Only five countries reported 
either that NCD surveillance was the responsibility of 
an external agency, or that no one had responsibility for 
NCD surveillance. While just under two-thirds of countries 
had population-based cancer registries, there has been 
considerable improvement in five years, particularly 
KEY FINDINGS
81Report of the 2015 Global NCD Survey
in the African Region which has seen the number of 
countries with population-based cancer registries 
more than double. Diabetes registries, however, were 
less prevalent (44% of countries) and 14% only of all 
countries had population-based diabetes registries.
Over half of all countries had conducted recent, national 
risk factor surveys on each of the main NCD risk factors 
in adults, except for salt/sodium intake, which had 
been surveyed in just over a third of countries. There 
is still considerable work to be done in many countries 
to establish surveillance systems which conduct national 
multi-risk factor surveys on a regular basis: 34% only 
of countries fully achieved NCD Progress Monitoring 
Indicator 3 on regular, comprehensive health 
examination surveys. 
NCD management
Much progress is still to be made in NCD management 
guidelines. While diabetes and cardiovascular 
disease guidelines were available in approximately 
two thirds of countries (64% and 71% respectively), 
guidelines for cancer and chronic respiratory 
diseases were less prevalent worldwide. Just over a 
third of countries (37%) had implemented guidelines 
for all four of the major NCDs. Although certain 
basic technologies, such as height, weight and blood 
pressure measurement, were widely available in most 
countries, other technologies, such as cholesterol 
and HbA1c testing, were less widely available, with 
a marked decline in availability corresponding to 
decreasing income group. Breast and cervical cancer 
screening programmes were widely available even 
in low-income countries, the Eastern Mediterranean 
Region being the notable exception to this. Many 
programmes were opportunistic only, and reached 
50% or less of the target population. HPV vaccination 
programmes were available in approximately one 
third of middle- and low-income countries only; 
however they were widely available in high-income 
countries. While programme coverage improved 
with increasing income group, many programmes 
in low-income countries reached less than 10% of 
the target population. The availability of medicines 
and procedures for treating NCDs showed a clear 
relationship with income group; this applied also 
to palliative care which was only widely available 
among high-income countries. Much progress 
remains to be made in the areas of availability for 
cardiovascular risk stratification and provision of care 
of acute stroke and stroke rehabilitation with well 
under a third of countries (21% and 24% respectively) 
worldwide offering these services in the majority of 
primary health-care facilities.
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As the product of a broad collaboration across various 
technical areas, the NCD CCS questionnaire is a 
unique tool that offers a wide-ranging view of the global 
response to NCDs. The breadth of the questionnaire, 
however, is not without its disadvantages. It was not 
possible, for example, to go into detail on any given 
topic or request documentation from countries for 
every response. However, the high response rate and 
high quantities of supporting documents submitted for 
selected questions lends strength to the survey results. 
Country responses were reviewed and validated 
against reliable data sources, where available, and 
most countries responded well to feedback from the 
WHO Secretariat. While the results were ultimately 
the response of a single focal point in the ministry 
of health, joint collaboration between focal point 
and local colleagues to complete the questionnaire 
was strongly encouraged. Most countries succeeded 
in following these instructions; nevertheless those 
with highly decentralized health systems may have 
found completing specific sections challenging and 
considered their responses to give an incomplete 
national picture. Although a glossary was available 
and the WHO Secretariat highly responsive to 
requests for clarification, there remained the possibility 
of variable interpretation of certain terminology 
throughout the questionnaire, which would negatively 
impact the accuracy of the results.
STRENGTHS  
AND LIMITATIONS  
OF THE SURVEY
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CONCLUSION
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The results of the 2015 NCD CCS highlight significant 
areas of growth and improvement in national responses 
to address the growing NCD burden. Significant 
achievement and progress has been made since the 
2014 survey with a continuation in the positive trend 
in stronger national level capacity since the initial 
survey of 2010. However, while overall progress is 
encouraging, there remain areas of concern where 
actions need to be prioritized. The following six key 
priorities are highlighted:
Funding for NCD activities
Greater leveraging of resources to fund essential programmatic work is still required in many 
low- and middle-income countries, particularly funding for primary prevention, screening and 
health promotion, palliative care, surveillance and capacity-building. 
Multisectoral coordination
Strengthened governance mechanisms are needed, in particular multisectoral NCD 
commissions or similar mechanisms to help oversee NCD engagement, policy coherence 
and accountability of sectors beyond health to bring about policy and programme 
coherence.
Policy implementation
Tangible progress in the availability of operational national integrated plans has been 
made, reflecting the increased importance countries are placing on the need to address 
NCDs and their risk factors. Efforts are still needed to ensure these plans are fully 
implemented and further focus is required to ensure the content of the plans reflect a 
comprehensive approach to addressing the four main NCDs and the four main risk factors. 
Policy implementation in the area of unhealthy diet in particular needs strengthening. 
I
II
III
PRIORITIES FOR 
FURTHER ACTION
87Report of the 2015 Global NCD Survey
Detection, treatment and care for those with existing NCDs
Improvements are still needed in the availability of guidelines for managing the main 
NCDs, particularly with cancer and chronic respiratory diseases. Broader availability 
of basic technologies to detect NCDs is needed, particularly in low-income countries. 
Cancer screening programmes need to become more systematic and reach a larger 
proportion of their target populations. 
Strengthen palliative care  
Provision of palliative care for people suffering with end-stage NCDs in the public health 
system needs strengthening, specifically in primary health care and in community or 
home-based care.
V
VI
Sustained surveillance
Considerable work is still needed in many countries to establish robust surveillance 
systems capable of conducting national multi-risk factor surveys at least every five years 
to track national targets and indicators, and check that interventions remain on course.  
IV
88
1. Global Health Estimates: Deaths by Cause, Age, 
Sex and Country, 2000–2012. Geneva, World 
Health Organization, 2014.
2. United Nations, General Assembly. Political 
declaration of the High-level Meeting of the 
General Assembly on the Prevention and Control 
of Non-communicable Diseases, A/66/L.1, 
16 September 2011 (http://www.un.org/
ga/search/view_doc.asp?symbol=A/66/L.1, 
accessed 6 June 2016).
3. United Nations, General Assembly. Outcome 
document of the High-level Meeting of the 
General Assembly on the Review of the Progress 
Achieved in the Prevention and Control of 
Non-communicable Diseases, 8 July 2014 
(http://www.un.org/en/ga/president/68/
pdf/letters/782014Non-communicable%20
diseases_Outcome%20Doc-8%20July%20
2014.pdf, accessed 9 June 2016).
4. Resolution WHA66.10. Follow-up to the Political 
Declaration of the High-level Meeting of the 
General Assembly on the Prevention and Control 
of Non-communicable Diseases. In: Sixty-sixth 
World Health Assembly, 20–28 May 2013. 
Geneva: World Health Organization, 2013 
(http://apps.who.int/gb/ebwha/pdf_files/
WHA66/A66_R10-en.pdf?ua=1 , accessed 9 
June, 2016).
5. Alwan AD, Maclean D, Mandil A. Assessment of 
national capacity for noncommunicable disease 
prevention and control: the report of a global survey, 
Geneva: World Health Organization, 2001 (http://
apps.who.int/iris/bitstream/10665/67305/1/
WHO_MNC_01.2.pdf, accessed 6 June 2016).
6. Global action plan for the prevention and 
control of noncommunicable diseases 2013–
2020. Geneva, World Health Organiza-
tion, 2013 (http://apps.who.int/iris/bitstre-
am/10665/94384/1/9789241506236_eng.
pdf, accessed 6 June 2016).
REFERENCES
89Report of the 2015 Global NCD Survey
90
91Report of the 2015 Global NCD Survey
ANNEXES
92
    WHO  
African Region
Algeria
Angola†
Benin
Botswana*
Burkina Faso
Burundi
Cabo Verde*
Cameroon
Central African Republic
Chad†
Comoros
Congo
Côte d’Ivoire*
Democratic Republic of the 
Congo*
Equatorial Guinea*
Eritrea
Ethiopia†
Gabon*
Gambia
Ghana
Guinea
Guinea-Bissau*
Kenya
Lesotho
Liberia*
Madagascar
Malawi
Mali
Mauritania
Mauritius*
Mozambique
Namibia*
Niger
Nigeria
Rwanda
Sao Tome and Principe
Senegal
Seychelles
Sierra Leone†
South Africa†
South Sudan*
Swaziland
Togo
Uganda
United Republic  
of Tanzania*
Zambia
Zimbabwe
    WHO Region  
of the Americas
Antigua and Barbuda†
Argentina
Bahamas†
Barbados
Belize
Bolivia (Plurinational State of)
Brazil
Canada
Chile
Colombia†
Costa Rica
Cuba
Dominica
Dominican Republic
Ecuador
El Salvador
Grenada†
Guatemala
Guyana†
Haiti†
Honduras
Jamaica
Mexico
Nicaragua
Panama
Paraguay
Peru
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the 
Grenadines†
Suriname
Trinidad and Tobago
United States of America
Uruguay
Venezuela (Bolivarian  
Republic of)*
    WHO  
Eastern Mediterranean 
Region
Afghanistan
Bahrain
Djibouti*
Egypt
Iran (Islamic Republic of)
Iraq
Jordan
Kuwait
Lebanon
Libya
Morocco
Oman
Pakistan
Qatar
Saudi Arabia
Somalia
Sudan
Syrian Arab Republic
Tunisia
United Arab Emirates
Yemen
ANNEX1
WHO MEMBER STATES  
AND SURVEY RESPONDENTS
93Report of the 2015 Global NCD Survey
    WHO  
European Region
Albania
Andorra
Armenia
Austria
Azerbaijan
Belarus†
Belgium
Bosnia and Herzegovina†
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Georgia
Germany
Greece
Hungary
Iceland
Ireland
Israel
Italy
Kazakhstan
Kyrgyzstan†
Latvia
Lithuania
Luxembourg*
Malta
Monaco
Montenegro
Netherlands
Norway
Poland
Portugal
Republic of Moldova
Romania
Russian Federation
San Marino
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Tajikistan
The former Yugoslav Republic 
of Macedonia
Turkey
Turkmenistan†
Ukraine
United Kingdom
Uzbekistan
    WHO South-East Asia 
Region
Bangladesh
Bhutan
Democratic People’s Republic 
of Korea
India
Indonesia
Maldives
Myanmar
Nepal
Sri Lanka
Thailand
Timor-Leste†
    WHO  
Western  
Pacific Region
Australia
Brunei Darussalam
Cambodia
China
Cook Islands*
Fiji
Japan
Kiribati
Lao People’s  
Democratic  
Republic
Malaysia
Marshall Islands
Micronesia (Federated States 
of)
Mongolia
Nauru
New Zealand
Niue
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa*
Singapore
Solomon Islands
Tonga
Tuvalu
Vanuatu
Viet Nam
* signifies a non-respondent country. All other countries responded to the survey.
†  signifies that the country responded to the 2015 survey but not to the 2010 or 2013 survey.  
(These countries were thus excluded from the multi-year comparisons.)
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ANNEX 2
LIST OF COUNTRIES BY 
WORLD BANK INCOME 
GROUPS
    HIGH INCOME
Andorra
Antigua and Barbuda
Argentina
Australia
Austria
Bahamas
Bahrain
Barbados
Belgium
Brunei Darussalam
Canada
Chile
Croatia
Cyprus
Czech Republic
Denmark
Equatorial Guinea
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Israel
Italy
Japan
Kuwait
Latvia
Lithuania
Luxembourg
Malta
Monaco
Netherlands
New Zealand
Norway
Oman
Poland
Portugal
Qatar
Republic of Korea
Russian Federation
Saint Kitts and Nevis
San Marino
Saudi Arabia
Seychelles
Singapore
Slovakia
Slovenia
Spain
Sweden
Switzerland
Trinidad and Tobago
United Arab Emirates
United Kingdom
United States of America
Uruguay
Venezuela (Bolivarian  
Republic of)
    UPPER-MIDDLE INCOME
Albania
Algeria
Angola
Azerbaijan
Belarus
Belize
Bosnia and Herzegovina
Botswana
Brazil
Bulgaria
China
Colombia
Cook Islands
Costa Rica
Cuba
Dominica
Dominican Republic
Ecuador
Fiji
Gabon
Grenada
Iran (Islamic Republic of)
Iraq
Jamaica
Jordan
Kazakhstan
Lebanon
Libya
Malaysia
Maldives
Marshall Islands
Mauritius
Mexico
Mongolia
Montenegro
Namibia
Nauru
Niue
Palau
Panama
Paraguay
Peru
Romania
Saint Lucia
Saint Vincent and the 
Grenadines
Serbia
South Africa
Suriname
Thailand
The former Yugoslav Republic 
of Macedonia
Tonga
Tunisia
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Turkey
Turkmenistan
Tuvalu
    LOWER-MIDDLE INCOME
Armenia
Bangladesh
Bhutan
Bolivia (Plurinational State of)
Cabo Verde
Cameroon
Congo
Côte d’Ivoire
Djibouti
Egypt
El Salvador
Georgia
Ghana
Guatemala
Guyana
Honduras
India
Indonesia
Kenya
Kiribati
Kyrgyzstan
Lao People’s Democratic 
Republic
Lesotho
Mauritania
Micronesia (Federated States 
of)
Morocco
Myanmar
Nicaragua
Nigeria
Pakistan
Papua New Guinea
Philippines
Republic of Moldova
Samoa
Sao Tome and Principe
Senegal
Solomon Islands
Sri Lanka
Sudan
Swaziland
Syrian Arab Republic
Tajikistan
Timor-Leste
Ukraine
Uzbekistan
Vanuatu
Viet Nam
Yemen
Zambia
    LOW INCOME
Afghanistan
Benin
Burkina Faso
Burundi
Cambodia
Central African Republic
Chad
Comoros
Democratic People’s Republic 
of Korea
Democratic Republic of the 
Congo
Eritrea
Ethiopia
Gambia
Guinea
Guinea-Bissau
Haiti
Liberia
Madagascar
Malawi
Mali
Mozambique
Nepal
Niger
Rwanda
Sierra Leone
Somalia
South Sudan
Togo
Uganda
United Republic of Tanzania
Zimbabwe 
Categories for this report were based on the income categories for 2015
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ANNEX 3 QUESTIONNAIRE
MODULES:
Country Profile of Capacity and Response  
to Noncommunicable Diseases (NCDs)
I
III
PUBLIC HEALTH 
INFRASTRUCTURE, 
PARTNERSHIPS AND 
MULTISECTORAL 
COLLABORATION FOR NCDs 
AND THEIR RISK FACTORS
HEALTH INFORMATION 
SYSTEMS, SURVEILLANCE AND 
SURVEYS FOR NCDs AND THEIR 
RISK FACTORS
STATUS OF NCD-RELEVANT 
POLICIES, STRATEGIES AND 
ACTION PLANS
CAPACITY FOR NCD EARLY 
DETECTION, TREATMENT AND 
CARE WITHIN THE HEALTH 
SYSTEM
II
IV
Purpose
• The purpose of this survey is to gauge your country capacity for responding to noncommunicable 
diseases. The four main types of noncommunicable diseases are cardiovascular diseases (such 
as heart attack and stroke), cancers, chronic respiratory diseases (such as chronic obstructed 
pulmonary disease and asthma) and diabetes. The main risk factors for NCDs are harmful use 
of alcohol, tobacco use, unhealthy diet, and physical inactivity. The term NCDs in this document 
includes prevention, control, and management of NCDs, including major risk factors. The objective 
of the survey is to guide WHO Member States, WHO regional offices and WHO headquarters in 
planning future actions and technical assistance required to address NCDs.
• This survey also will provide the basis for ongoing assessment of changes in country capacity and 
response.
• The use of standardized questions allows for comparisons of country capacities and responses. This 
survey is divided into four modules which assess the four key aspects of NCD prevention and control.
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Process
• The survey is intended to assess national level capacity and response to NCDs. If responsibility for 
health is decentralized to sub-national levels, it can also be applied at sub-national levels.  
• A focal point or survey coordinator will need to be identified to coordinate and ensure survey completion. 
However, in order to provide a complete response, a group of respondents with expertise in the topics 
covered in the modules will be needed. Please use the following table to indicate the names and titles 
of all of those who have completed the survey and which sections they have completed. 
• Please note that while there is space to indicate “Don’t Know” for most questions, there should be very 
few of these. If someone is filling in numerous “Don’t Knows”, another person who is more aware of 
this information should be found to complete this section.
• In order to validate responses, documentation will be requested for the affirmative responses 
throughout the questionnaire. Please make every effort to provide electronic copies of the requested 
documentation. If you are unable to provide electronic copies through the provided links, please ask 
your regional focal point for an alternative means to submit documentation.
Information on those who completed the survey
Who is the focal point for completion of this survey?
Name:
Position:
Contact Information:
Sections completed:
Name and contact information of 
others completing survey
Sections completed
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PUBLIC HEALTH 
INFRASTRUCTURE, 
PARTNERSHIPS AND 
MULTISECTORAL 
COLLABORATION FOR NCDS 
AND THEIR RISK FACTORS 
1a
Is there a unit/branch/department in the MOH or equivalent 
with responsibility for NCDs and their risk factors? 
The questions in this module relate to the presence of a unit or division within the 
ministry of health (MOH) dedicated to NCDs and risk factors, staff and funding. 
They also assess the existence of fiscal interventions as incentives to influence health 
behaviour and/or to raise funds for health-related activities. Finally, they assess the 
existence of a formal multisectoral mechanism to coordinate NCD-related activities 
in sectors outside of health. Responses to these questions enable reporting against 
NCD Global Action Plan process indicators and UN High-level Meeting national 
commitment progress indicators.
Please indicate the number of full-time technical/professional  
staff in the unit/branch/department.
Is there funding for the following NCD and risk factor 
activities/functions? 
Yes
i) Primary prevention
ii) Health promotion
iii) Early detection/screening
iv) Health care and  treatment 
v) Surveillance, monitoring and evaluation
vi)  Capacity-building 
vii) Palliative care
No Don’t know IF NO: Go to Question 2.
0 2-5 11 or more
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
1 6-10 Don’t know
1
2
I
If at least one Yes to above questions:
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3a
Is your country implementing  
any of the following fiscal interventions?
Is there a national multisectoral commission, agency or 
mechanism to oversee NCD engagement, policy coherence 
and accountability of sectors beyond health?
3
4
2a
What are the major sources of funding for NCDs and their risk 
factors? 
More than one can apply, rank order them where: 
1 = Largest source; 2 = Next largest; 3 = Others
How are these funds primarily used? 
NO: Go to MODULE II
General government revenues 
Health insurance
International /national donors
Earmarked taxes on alcohol, tobacco, etc. 
Other (specify) 
Don’t know
taxation on alcohol 
taxation on tobacco (excise and non-excise taxes)
taxation on sugar-sweetened beverages
taxation on foods high in fat, sugar or salt 
price subsidies for healthy foods
taxation incentives to promote physical activity
others (specify)
Towards general revenue
General funds for health and health services
For influencing health behaviours 
Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
If Yes to at least one of the above, other than price subsidies:
100
4b
4c
Which of the following are members?
Indicate its stage:
What settings are covered by the commission,  
agency or mechanism?
Other non-health government ministries  
(e.g.ministry of sport, ministry of education)
United Nations agencies
Other international institutions
Academia (including research centres)
Nongovernmental organizations/community-based organizations/civil society
Private sector 
Other (specify)
Don’t know
Operational
Under development
Not in effect
Don’t know
(Check all that apply)
Schools
Worksites
Cities
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
4a
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Please note that disease- and risk factor-specific policies, strategies, and action plans 
will be reported in other questions later in this module.
Are NCDs included in your national development agenda?
Are there a set of time-bound national targets for these indicators?
Yes
Yes
Yes
Yes
No
No
No
No
Don’t know
Don’t know
Don’t know
Don’t know
STATUS OF NCD-RELEVANT 
POLICIES, STRATEGIES, AND 
ACTION PLANS
The questions in this module relate to the presence of policies, strategies, or action 
plans. Questions differentiate between integrated policies/strategies/action plans 
that address several risk factors or diseases, and policies/strategies/action plans that 
address a specific disease or risk factor. Additional questions address the existence 
of specific policies related to the cost-effective interventions for NCDs. Responses to 
these questions enable reporting against NCD Global Action Plan process indicators 
and UN High-level Meeting national commitment progress indicators.
Are NCDs included in your national health plan?
Yes No Don’t know
II
IIa
1a
1b
2a
Are there a set of national NCD indicators?
Does your country have a national NCD policy, strategy or 
action plan which integrates several NCDs and their risk 
factors?
IF Yes:
IF NO: Go to Question 4
2
3
INTEGRATED POLICIES,  
STRATEGIES, AND ACTION PLANS 
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Does it combine early detection, treatment and care for:
Does it include palliative care for patients with NCDs?
Cancer
Cardiovascular diseases
Chronic respiratory diseases
Diabetes
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
3c
3d
3eIndicate its stage: 
Operational
Under development
Not in effect
Don’t know 
If Operational:
3e-i) What was the first year of implementation?
3e-ii) What year will it expire? 
Please provide the following information about the policy, 
strategy or action plan:
Title: 
Does it address one or more of the following major risk factors?
Harmful use of alcohol
Unhealthy diet
Physical inactivity
Tobacco
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
3a
3b
Is it a policy/strategy?
Is it an action plan?
Is it multisectoral?
Is it multistakeholder?
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
IF Yes:
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Indicate its stage: 
Operational
Under development
Not in effect
Don’t know 
Yes for all cancers or cancer in general
Yes but only for specific cancers (specify:  )
No
Don’t Know
If Operational:
4b-i) What was the first year of implementation?
4b-ii) What year will it expire? 
IIb POLICIES, STRATEGIES, ACTION PLANS FOR MAJOR DISEASES
4
5
The questions in this sub-section only refer to policies, strategies and action plans 
that are specific to a major NCD. If your integrated policy, strategy or action plan 
addresses the NCD, you do not need to re-enter that information.  
Write the title 4a
4b
Is it a policy/strategy?
Is it an action plan?
Yes No Don’t know
Yes No Don’t know
IF Yes:
Is there a policy, strategy, or action plan for cardiovascular 
diseases in your country?
Is there a policy, strategy, or action plan for cancer or some
particular cancer types in your country? 
Yes No Don’t know IF NO: Go to Question 5
IF NO: Go to Question 6
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Is it a policy/strategy?
Is it an action plan?
Yes No Don’t know
Yes No Don’t know
If yes, provide the following for the general cancer policy/strategy/
action plan or, if there isn’t one, for the most important specific 
cancer policy/strategy/action plan:
Indicate its stage: 
Operational
Under development
Not in effect
Don’t know 
If Operational:
5b-i) What was the first year of implementation?
5b-ii) What year will it expire? 
Write the title 5a
6a
5b
6bIndicate its stage: 
Operational
Under development
Not in effect
Don’t know 
If Operational:
6b-i) What was the first year of implementation?
6b-ii) What year will it expire? 
Write the title 
Is it a policy/strategy?
Is it an action plan?
Yes No Don’t know
Yes No Don’t know
IF Yes:
Is there a policy, strategy, or action plan for diabetes in 
your country?
Yes No Don’t know IF NO: Go to Question 7
6
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7a
7b
8a
Indicate its stage: 
Operational
Under development
Not in effect
Don’t know 
If Operational:
7b-i) What was the first year of implementation?
7b-ii) What year will it expire? 
Write the title 
Is it a policy/strategy?
Is it an action plan?
Is it a policy/strategy?
Is it an action plan?
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
IF Yes:
IF Yes:
Is there a policy, strategy, or action plan for chronic 
respiratory diseases in your country?
Is there a policy, strategy, or action plan for another  
non-communicable disease of importance in your country? 
Yes
Yes
No
No
Don’t know
Don’t know
IF NO: Go to Question 8
IF NO: Go to Question 9
7
8
Please provide the following information about the policy/strategy /
action plan. If there is more than one, please provide the information for 
the most recent one.
Write the title 
Please specify which NCD: 
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Indicate its stage: 
Operational
Under development
Not in effect
Don’t know 
If Operational:
8b-i) What was the first year of implementation?
8b-ii) What year will it expire? 
8b
Indicate its stage: 
Operational
Under development
Not in effect
Don’t know 
If Operational:
9b-i) What was the first year of implementation?
9b-ii) What year will it expire? 
POLICIES, ACTION PLANS, 
STRATEGIES FOR NCD RISK FACTORS
The questions in this sub-section only refer to policies, strategies and action plans 
that are specific to an NCD risk factor. If your integrated policy, strategy or action 
plan addresses the risk factor, you do not need to re-enter that information.  
Write the title 
Is it a policy/strategy?
Is it an action plan?
Yes No Don’t know
Yes No Don’t know
IF yes:
Is there a policy, strategy, or action plan for for reducing the 
harmful use of alcohol in your country?
Yes No Don’t know IF NO: Go to Question 10
IIc
9a
9b
9
107Report of the 2015 Global NCD Survey
10a
11a
10b
11b
10
11
Indicate its stage: 
Indicate its stage: 
Operational
Under development
Not in effect
Don’t know 
Operational
Under development
Not in effect
Don’t know 
If Operational:
If Operational:
10 b-i) What was the first year of implementation?
11 b-i) What was the first year of implementation?
10 b-ii) What year will it expire? 
11 b-ii) What year will it expire? 
Write the title 
Write the title 
Is it a policy/strategy?
Is it an action plan?
Is it a policy/strategy?
Is it an action plan?
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
IF yes:
IF yes:
Is there a policy, strategy, or action plan for reducing 
overweight/obesity in your country?
Is there a policy, strategy, or action plan for reducing physical 
inactivity and/or promoting physical activity in your country?
Yes
Yes
No
No
Don’t know
Don’t know
IF NO: Go to Question 11
IF NO: Go to Question 12
108
Indicate its stage: 
Operational
Under development
Not in effect
Don’t know 
If Operational:
12 b-i) What was the first year of implementation?
12 b-ii) What year will it expire? 
Write the title 
Is it a policy/strategy?
Is it an action plan?
Yes No Don’t know
Yes No Don’t know
IF yes:
Is there a policy, strategy, or action plan to decrease tobacco 
use in your country? 
Yes No Don’t know IF NO: Go to Question 13
12a
12b
12
Indicate its stage: 
Operational
Under development
Not in effect
Don’t know 
If Operational:
13 b-i) What was the first year of implementation?
13 b-ii) What year will it expire? 
Write the title 
Is it a policy/strategy?
Is it an action plan?
Yes No Don’t know
Yes No Don’t know
IF yes:
Is there a policy, strategy, or action plan for reducing 
unhealthy diet related to NCD and/or promoting a healthy 
diet in your country?
Yes No Don’t know IF NO: Go to Question 14
13a
13b
13
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Indicate its stage: 
Operational
Under development
Not in effect
Don’t know 
COST-EFFECTIVE POLICIES FOR NCDS 
AND RELATED RISK FACTORS
IF yes:
Is there a policy and/or plan on NCD-related research 
including community-based research and evaluation  
of the impact of interventions and policies?
Yes No Don’t know IF NO: Go to Question 15
14a
14
IId
Who is responsible for overseeing enforcement and complaints?
Government 
Food industry 
Independent regulator
Other, please specify:
15a
15b
15
Are the policies: 
Voluntary/self-regulating 
Government legislation  
Don’t know
IF yes:
Is your country implementing any policies to reduce the 
impact on children of marketing of foods and non-alcoholic 
beverages high in saturated fats, trans-fatty acids, free 
sugars, or salt?
Yes No Don’t know
Do they include steps taken to address the effects of cross-border 
marketing of food and non-alcoholic beverages on children?
15 c-i) What was the first year of implementation?
15c
Yes No Don’t know
IF NO: Go to Question 16
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Is your country implementing the International Code of Marketing of 
Breast-Milk Substitutes through adoption of national laws?
Is your country implementing any national policies that limit saturated 
fatty acids and virtually eliminate industrially produced trans fats (i.e. 
partially hydrogenated vegetable oils) in the food supply?
17a
16
17
Are the policies: 
Voluntary/self-regulating 
Government legislation  
Don’t know
IF yes:
Yes
Yes
No
No
Don’t know
Don’t know IF NO: Go to Question 18
Is your country implementing any policies to reduce 
population salt consumption?
Yes No Don’t know IF NO: Go to Question 19
Product reformulation by industry 
across the food supply
Regulation of salt content of food
Public awareness programme
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
Are these targeted at: 18a
18b
18
Are the policies: 
Voluntary/self-regulating 
Government legislation  
Don’t know
IF yes:
111Report of the 2015 Global NCD Survey
Has your country implemented any national public 
awareness programme on diet within the past 5 years? 
Yes No Don’t know IF NO: Go to Question 20
If yes, please provide details of the public awareness programme(s):19a
19
Has your country implemented any national public 
awareness programme on physical activity within the past 
5 years? 
Yes No Don’t know IF NO: Go to Question 21
If yes, please provide details of the public awareness programme(s):20a
20
21a
Does your country have nutrition labelling regulation, in 
line with international standards, in particular the Codex 
Alimentarius, for pre-packaged foods?
Yes
Yes
No
No
Don’t know
Don’t know
IF NO:  Go to MODULE III
Does the regulation have norms in place for front-of package labelling 
that allow for quick and easy identification of energy-dense nutrient-
poor products and sugar-sweetened beverages which take into 
consideration Codex norms?
IF yes:
21
112
In your country, who has responsibility for surveillance of 
NCDs and their risk factors? 1
III
STATUS OF NCD-RELEVANT 
POLICIES, STRATEGIES, AND 
ACTION PLANS
The questions in this module assess surveillance relating to the mortality, morbidity and 
risk factor reporting systems of each country and whether NCD mortality, morbidity and 
risk factor data were included in their national health reporting systems. Responses to 
these questions enable reporting against NCD Global Action Plan process indicators 
and UN High-level Meeting national commitment progress indicators.
An office/department/administrative division within the MOH exclusively dedicated 
to NCD surveillance
An office/department/ administrative division within the MOH not exclusively 
dedicated to NCD surveillance
Responsibility is shared across several offices/departments/administrative divisions 
within the MOH
Coordination is by an external agency, such as an NGO or statistical organization
No one has this responsibility
Don’t know
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DATA INCLUDED IN THE NATIONAL 
HEALTH INFORMATION SYSTEM 
(National health information system refers to the annual or regular reporting system  
of the National Statistical Office or MOH)
Does your country have a system for collecting mortality 
data by cause of death on a routine basis?
Does your country have a cancer registry?
Is there a civil/vital registration system?
Is there a sample registration system?
What is the latest year for which data are available?
Yes
Yes
Yes
Yes
No
No
No
No
Don’t know
Don’t know
Don’t know
Don’t know
IF NO: Go to Question 3
IF NO: Go to Question 4
IF yes:
IF yes:
Can the data collected be disaggregated by:
Age 
Gender
Other sociodemographic factor 
Are the data collected population-based, hospital-based, or other?
Population-based
Hospital-based
Other (specify:  )
Don’t know
Yes No Don’t know
Yes No Don’t know
Yes No Don’t know
IIIa
2a
3a
2b
2c
2d
2
3
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What is the latest year for which data are available?
What is the latest year for which data are available?
4a
4b
4d
3b
4c
3c
4
Is the coverage of the registry national or subnational?
Does the registry include data on any chronic complications which are 
updated as the patient’s complications status changes?     
Is the coverage of the registry national or subnational?
National (covers the whole population of the country) 
Subnational (covers only the population of a defined region, not the whole country)
Don’t know
National (covers the whole population of the country) 
Subnational (covers only the population of a defined region, not the whole country)
Don’t know
Does your country have a diabetes registry? 
Yes
Yes
No
No
Don’t know
Don’t know
IF NO: Go to Question 5
IF yes:
Are the data collected population-based, hospital-based, or other?
Population-based
Hospital-based
Other (specify:  )
Don’t know
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IIIb RISK FACTOR SURVEILLANCE 
5a)  
Harmful alcohol 
use 
5b)  
Low fruit and 
vegetable 
consumption
5c)  
Physical 
inactivity
5d)  
Tobacco use
5) Have surveys of 
risk factors (either 
single or multiple  
risk factors) been 
conducted in your 
country for any of 
the following:
(Please fill in all 
columns, start in the 
first row, going left 
to right, and then 
continue left to right 
across the second 
row)
No No NoNo
Don’t know Don’t know Don’t knowDon’t know
Yes Yes YesYes
National 
Subnational
Don’t know
National 
Subnational
Don’t know
National 
Subnational
Don’t know
National 
Subnational
Don’t know
Measured
Self-reported
Don’t know
National 
Subnational
Don’t know
National 
Subnational
Don’t know
National 
Subnational
Don’t know
i-1) Was it: i-1) Was it: i-1) Was it:
i-2) Was it:
i-1) Was it:
i-1) Was it: i-1) Was it: i-1) Was it:
i-3) When was the  
last survey conducted?  
(give year) 
i-3) When was the  
last survey conducted?  
(give year) 
i-3) When was the  
last survey conducted?  
(give year) 
i-4) When was the  
last survey conducted?  
(give year) 
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don’t know
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don’t know
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don’t know
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don’t know
i-2) How often is the 
survey conducted?
i-2) How often is the 
survey conducted?
i-2) How often is the 
survey conducted?
i-3) How often is the 
survey conducted?
No
Don’t know
Yes No
Don’t know
Yes No
Don’t know
YesNo
Don’t know
Yes
No
Don’t know
Yes No
Don’t know
Yes No
Don’t know
Yes
No
Don’t know
Yes
IF NO:  
Go to next comlumn
IF yes:
IF NO:  
Go to next comlumn
IF yes:
IF NO:  
Go to next comlumn
IF yes:
IF NO:  
Go to next comlumn
IF yes:
IF yes: IF yes: IF yes:IF yes:
IF yes: IF yes: IF yes:
i) Was there 
a survey on 
adolescents? 
i) Was there 
a survey on 
adolescents? 
i) Was there 
a survey on 
adolescents? 
i) Was there 
a survey on 
adolescents? 
ii) Was there a 
survey on adults? 
ii) Was there a 
survey on adults? 
ii) Was there a 
survey on adults? 
ii) Was there a 
survey on adults? 
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5e) Raised 
blood glucose/
diabetes
5f) Raised total 
cholesterol
5g) Raised 
blood pressure/
hypertension
5h) Overweight 
and obesity
5i) Salt/sodium 
intake
5a)  
Harmful alcohol 
use 
5b)  
Low fruit and 
vegetable 
consumption
5c)  
Physical 
inactivity
5d)  
Tobacco use
No No No No No
Don’t know Don’t know Don’t know Don’t know Don’t know
Yes Yes Yes Yes Yes
Measured
Self-reported
Don’t know
Measured
Self-reported
Don’t know
Measured
Self-reported
Don’t know
Measured by 24-hr 
urine collection
Measured by 12-hr 
urine collection
Measured by spot 
urine collection
Measured by 
combination of 
methods
Self-reported
Don’t know
i) Was it: i) Was it: i) Was it: i) Was it:
ii-3) When was the  
last survey conducted?  
(give year) 
ii-3) When was the  
last survey conducted?  
(give year) 
ii-5) When was the  
last survey conducted?  
(give year) 
ii-3) When was the  
last survey conducted?  
(give year) 
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don’t know
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don’t know
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don’t know
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don’t know
ii-2) How often is the 
survey conducted?
ii-2) How often is the 
survey conducted?
ii-4) How often is the 
survey conducted?
ii-2) How often is the 
survey conducted?
No
Don’t know
Yes
IF NO:  
Go to next comlumn
IF yes:
IF NO:  
Go to next comlumn
IF yes:
IF NO:  
Go to next comlumn
IF yes:
IF NO:  
Go to next comlumn
IF yes:
IF NO: Go to 
MODULE IV.
IF yes:
Measured
Self-reported
Don’t know
i-1) Was it:
IF yes:
i) Was there 
a survey on 
adolescents? 
ii-2) Did it assess 
physical activity for 
work/in the household, 
for transport and during 
leisure time?
No
Don’t know
Yes
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5e) Raised 
blood glucose/
diabetes
5f) Raised total 
cholesterol
5g) Raised 
blood pressure/
hypertension
5h) Overweight 
and obesity
5i) Salt/sodium 
intake
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other  
Don’t know
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other  
Don’t know
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other  
Don’t know Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other  
Don’t know
iii) How often is the 
survey conducted?
iii) How often is the 
survey conducted?
iii) How often is the 
survey conducted?
iii) How often is the 
survey conducted?
iv) When was the last 
survey conducted?  
(give year)
iv) When was the last 
survey conducted?  
(give year) 
iv) When was the last 
survey conducted?  
(give year) 
iv) When was the last 
survey conducted?  
(give year) 
National 
Subnational
Don’t know
National 
Subnational
Don’t know
Measured
Self-reported
Don’t know
Measured
Self-reported
Don’t know
i-2) Was it:
ii-2) Was it:
i-1) Was it:
ii-1) Was it:
i-4) When was the  
last survey conducted?  
(give year) 
ii-4) When was the  
last survey conducted?  
(give year) 
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don’t know
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don’t know
i-3) How often is the 
survey conducted?
ii-3) How often is the 
survey conducted?
No
Don’t know
Yes
IF yes:
IF yes:
ii) Was there a 
survey on adults? 
National 
Subnational
Don’t know
ii) Was it:
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No
Don’t know
Yes
No
Don’t know
Yes (specify  
cancer types) 
No
Don’t know
Yes
No
Don’t know
Yes
No
Don’t know
Yes, fully
Yes, partially
No
Don’t know
Yes, fully
Yes, partially
No
Don’t know
Yes, fully
Yes, partially
No
Don’t know
Yes, fully
Yes, partially
CAPACITY FOR EARLY 
DETECTION, TREATMENT AND 
CARE OF NCDS WITHIN THE 
HEALTH SYSTEM
The questions in this module assess the capacity of health-care systems related to 
NCD early detection, treatment and care within the primary health-care sector. 
Specific questions focus on the availability of guidelines or protocols to treat major 
NCDs, and the tests, procedures and equipment related to NCDs within the health-
care system. The questions also assess the availability of palliative care services for 
NCDs. Responses to these questions enable reporting against NCD Global Action 
Plan process indicators and UN High-level Meeting national commitment progress 
indicators.
IV
1
Please indicate whether evidence-based national 
guidelines/protocols/standards are available for the 
management (diagnosis and treatment) of each of the 
major NCDs through a primary care approach recognized/
approved by government or competent authorities. Where 
guidelines/protocols/standards are available, please 
indicate their implementation status and when they were 
last updated.
Cardiovascular 
Disease
Diabetes Cancer Chronic 
Respiratory 
Disease
1a) Are they 
available?
1b) Are 
they being 
implemented?
1c) When 
were they last 
updated?
119Report of the 2015 Global NCD Survey
No
Don’t know
Yes
No
Don’t know
Yes
No
Don’t know
Yes
No
Don’t know
Yes
No
Don’t know
Yes, fully
Yes, partially
No
Don’t know
Yes, fully
Yes, partially
No
Don’t know
Yes, fully
Yes, partially
No
Don’t know
Yes, fully
Yes, partially
For each of the major NCDs, please indicate the availability 
of standard criteria for the referral of patients from 
primary care level to a higher level of care (secondary/
tertiary). Where standard criteria are available, please 
indicate their implementation status.
Indicate the availability* of the following basic technologies 
for early detection, diagnosis/monitoring of NCDs in the 
primary care facilities of the public and private health 
sector where: Generally available = 1; Generally not 
available = 2; Don’t know = 3.
Cardiovascular 
Disease
Diabetes Cancer Chronic 
Respiratory 
Disease
2a) Are they 
available?
2b) Are 
they being 
implemented?
Availability in 
the primary care 
facilities of the 
public health sector
(1, 2, or 3)
Availability in 
the primary care 
facilities of the 
private health 
sector 
(1, 2, or 3)
Overweight and obesity
3a) Measuring of weight
3b) Measuring of height
Diabetes mellitus
3c) Blood glucose measurement
3d) Oral glucose tolerance test
3e) HbA1c test
3f) Dilated fundus examination
3g) Foot vibration perception by tuning fork 3h) Foot vascular 
status by Doppler
3i) Urine strips for glucose and ketone measurement
Cardiovascular disease
3j) Blood pressure measurement
3k) Total cholesterol measurement
3l) Urine strips for albumin assay
Asthma and COPD
3m) Peak flow measurement spirometry
* Generally available: in 50% or more of health-care 
facilities
Generally not available: in less than 50% of health-care 
facilities
2
3
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Please indicate if there is a national screening programme 
targeting the general population for the following cancers 
and, if yes, provide details.
4
Cancers Screening 
method  
(indicate only  
one, the most 
widely used)
Population 
targeted by the 
programme
Type of 
programme
Screening 
coverage
No
Don’t know
Yes
Breast
If NO: Go to next row
No
Don’t know
Yes
Cervix
If NO: Go to next row
No
Don’t know
Yes
Colon
If NO: Go to next row
No
Don’t know
Yes
Prostate
If NO: Go to 
Question 5
Mammography 
screening
PAP smear
Colonoscopy
Prostate palpation
Don’t know
HPV test
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Less than 10%
Less than 10%
Less than 10%
Less than 10%
10% to 50%
10% to 50%
10% to 50%
10% to 50%
70% or more
70% or more
70% or more
70% or more
Don’t know
Don’t know
Don’t know
Don’t know
More than 50% 
but less than 70%
More than 50% 
but less than 70%
More than 50% 
but less than 70%
More than 50% 
but less than 70%
Opportunistic 
screening
Opportunistic 
screening
Opportunistic 
screening
Opportunistic 
screening
Organized 
population-based 
screening
Organized 
population-based 
screening
Organized 
population-based 
screening
Organized 
population-based 
screening
Clinical breast exam
Visual inspection
Faecal test
PSA
Women aged 
to
Other, specify:
Women aged 
to
Other, specify:
People aged 
to
Other, specify:
Men aged 
to
Other, specify:
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Breast Cervix Colon Prostate Oral
Programme/guidelines to 
strengthen early detection of first 
symptoms at primary health care 
level
Clearly defined referral system 
from primary care to secondary 
and tertiary care
No
Don’t  
know
Yes
No
Don’t  
know
Yes
No
Don’t  
know
Yes
No
Don’t  
know
Yes
No
Don’t  
know
Yes
No
Don’t  
know
Yes
No
Don’t  
know
Yes
No
Don’t  
know
Yes
No
Don’t  
know
Yes
No
Don’t  
know
Yes
Please indicate if early detection of the following cancers 
by means of rapid identification of the first symptoms 
is integrated into primary health care services and if 
there is a clearly defined referral system from primary 
care to secondary/tertiary care for suspect cases (in 
low- and middle-income countries this set of measures 
may be designated as an “early diagnosis” or “clinical 
downstaging” programme):
Is there a national HPV vaccination programme  
under implementation?
Who is targeted by the programme?
Who is targeted by the programme?
What year did the programme begin? 
Yes No Don’t know IF NO: Go to Question 7
If yes, please provide the following details of the programme:
Girls aged   to 
Other (specify: )
Don’t know
Less than 10%
10% to 50%
More than 50% but less than 70%
70% or more
Don’t know
5
6
6a
6b
6c
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Describe the availability* of the medicines below in the 
primary care facilities of the public health sector, where:  
Generally available = 1; Generally not available = 2;  
Don’t know = 3.
Indicate the availability* of the following procedures for 
treating NCDs in the publicly funded health system, where: 
Generally available = 1; Generally not available = 2;  
Don’t know = 3.
7
8
* Generally available: in 50% or more pharmacies
 Generally not available: in less than 50% of pharmacies
* Generally available: in 50% or more of health-care facilities
Generally not available: in less than 50% of health-care facilities
Generic drug name Availability
7a) Insulin
7b) Aspirin (100 mg)
7c) Metformin
7d) Thiazide Diuretics
7e) ACE Inhibitors
7f) CC Blockers
7g) Beta Blockers
7h) Statins
7i) Oral morphine
7j) Steroid inhaler
7k) Bronchodilator
7l) Sulphonylurea(s)
Procedure name Availability*
8a) Retinal photocoagulation
8b) Renal replacement therapy by dialysis 
8c) Renal replacement by transplantation
8d) Coronary bypass or stenting
8e) Thrombolytic therapy (streptokinase) for acute myocardial infarction
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Indicate the number of treatment centres which offer 
radiotherapy (centres with external beam therapy 
equipment like linear accelerators or cobalt 60 machines):
Detail the cancer diagnosis and treatment services  
in the public sector:
Detail the cancer diagnosis and treatment services  
in the public sector:
Number of public centres: 
Number of public laboratories: 
Number of private centres: 
Number of private laboratories: 
Don’t know
Don’t know
Don’t know
Don’t know
* Generally available: in 50% or more of health-care facilities
Generally not available: in less than 50% of health-care facilities
Service Availability*
Cancer centres or cancer 
departments at tertiary 
level
Pathology services 
(laboratories)
Cancer surgery
Subsidized 
chemotherapy
8e) Thrombolytic therapy 
(streptokinase) for acute 
myocardial infarction
Generally available and affordable for the majority of patients 
Generally not available or affordable for the majority of patients
Don’t know
Generally available and affordable for the majority of patients 
Generally not available or affordable for the majority of patients
Don’t know
Generally available and affordable for the majority of patients 
Generally not available or affordable for the majority of patients
Don’t know
Generally available and affordable for the majority of patients 
Generally not available or affordable for the majority of patients
Don’t know
Generally available and affordable for the majority of patients 
Generally not available or affordable for the majority of patients
Don’t know
9
11
10
(If you don’t know the exact number, just give an interval, for example “between 2 and 5”.)
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12Indicate the availability* of palliative care for patients  with NCD in the public health system:
*Generally available: reaches 50% or more patients
  Generally not available: reaches less than 50% of patients
In primary health care:
In community or home-based care:
Generally available 
Generally not available
Don’t know 
Generally available 
Generally not available
Don’t know 
12a
12b
13b
What proportion of primary health care facilities are offering 
cardiovascular risk stratification for the management of 
patients at high risk for heart attack and stroke?
What percentage of public sector health facilities have 
provision for care of acute stroke and rehabilitation? 
13
14
Which CVD risk scoring chart is used?
None
Less than 10%
10% to 50%
More than 50% 
Don’t know
None
Less than 10%
10% to 50%
More than 50% 
Don’t know
WHO/ISH risk prediction charts
Others (specify  ) 
Don’t know
If more than none: 
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What percentage of public sector health facilities have 
provision for secondary prevention of rheumatic fever and 
rheumatic heart disease? 
None
Less than 10%
10% to 50%
More than 50% 
Don’t know
15
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ANNEX 4
GLOSSARY OF TERMS USED 
IN THE SURVEY
Academia: Educational institutions, especially 
those for higher education.
Broadcast media: Media which is broadcast to 
the public through radio and television.
Cancer: A generic term for a large group of 
diseases that can affect any part of the body. 
Other terms used are malignant tumours and 
neoplasms. One defining feature of cancer is the 
rapid creation of abnormal cells that grow beyond 
their usual boundaries, and which can then invade 
adjoining parts of the body and spread to other 
organs. 
Cancer registry: A systematic collection of data 
on cancer cases in a certain region or a certain 
hospital, the initial aim being to count the number 
of cancer cases to clarify the magnitude of the 
problem. WHO advises national coverage by 
population-based registry in small countries only.
Capacity-building: The development of 
knowledge, skills, commitment, structures, systems 
and leadership to enable effective action. 
Cardiovascular disease: A group of disorders of 
the heart and blood vessels that includes coronary 
heart disease, cerebrovascular disease, peripheral 
arterial disease, rheumatic heart disease, congenital 
heart disease, deep vein thrombosis and pulmonary 
embolism.
Cardiovascular risk assessment: Use of risk 
prediction charts to indicate the risk of a fatal or 
non-fatal major cardiovascular event in the next 
5–10 years. Based on the assessment, people can 
be stratified into different levels of risk which will 
helps in management and follow up.
Chronic respiratory diseases: Diseases of the 
airways and other structures of the lung, the most 
widespread being: asthma, chronic obstructive 
pulmonary disease, occupational lung diseases and 
pulmonary hypertension.
Civil registration: The system by which a 
government records the vital events of its citizens 
and residents, such as births, deaths and marital 
status, and cause of death.
Collaboration: A recognized relationship between 
different groups with a defined purpose.
Community: A specific group of people, often 
living in a defined geographical area, who share a 
common culture, values and norms and are arranged 
in a social structure according to relationships which 
the community has developed over a period of time. 
Members of a community exhibit some awareness of 
their identity as a group, and share common needs 
and a commitment to meeting them.
Cross-border marketing: Marketing originated 
in one country that crosses national borders 
through broadcast media and internet, print media, 
sponsorship of events and programmes or any other 
media or communication channel. It includes both 
in-flowing and out-flowing cross-border marketing.
Determinants of health: The range of personal, 
social, economic and environmental factors which 
determine the health status of individuals or 
populations. 
Diabetes: A disease that occurs either when 
the pancreas does not produce enough insulin or 
when the body cannot effectively use the insulin it 
produces.
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Early detection/screening: Measures 
preformed in order to identify individuals who have 
early stages of disease (with apparent symptoms in 
the case or early detection and without in the case 
of screening).
Earmarked taxes: Taxes which are collected and 
used for a specific purpose.
Fiscal interventions: Measures taken by the 
government such as taxes and subsidies.
Free sugars: Monosaccharides and disaccharides 
added to foods by the manufacturer, cook or 
consumer, plus sugars naturally present in honey, 
syrups and fruit juices.
Full immunization coverage: The proportion of 
people in the population targeted by the programme 
who actually received the full dose(s) of vaccine.
General government revenue: The money 
received from taxation, and other sources, such as 
privatization of government assets, to help finance 
expenditures.
Health: A state of complete physical, social and 
mental well-being, and not merely the absence 
of disease or infirmity. A resource for everyday 
life which permits people to lead an individually, 
socially and economically productive life. A positive 
concept emphasizing social and personal resources 
as well as physical capabilities.
Health behaviour: Any activity undertaken by an 
individual, regardless of actual or perceived health 
status, for the purpose of promoting, protecting or 
maintaining health, whether or not such behaviour is 
objectively effective towards that end.
Health care and treatment: The diagnosis and 
treatment of diseases.
Health-care facility: Facilities which provide 
health services. These may include mobile clinics, 
pharmacies, laboratories, primary health-care 
clinics, specialty clinics, and private and faith-based 
establishments.
Health promotion: The process of enabling 
people to increase control over, and to improve 
their health.
Healthy diet: A diet throughout the life-course 
which helps prevent malnutrition in all its forms 
as well as a range of noncommunicable diseases 
(NCDs) and conditions. The exact make-up of a 
healthy, balanced diet varies depending on the 
individual needs, such as age, sex, lifestyle, degree 
of physical activity). For adults a healthy diet contains 
fruits, vegetables, legumes, nuts and whole grains 
and should be limited in free sugars, salt, total fat, 
saturated fats and free of industrial trans fats. 
International Code of Marketing of Breast-
milk Substitutes: An international health policy 
framework that recommends restrictions on the 
marketing of breast-milk substitutes, such as infant 
formula, to ensure that mothers are not discouraged 
from breastfeeding and that substitutes are used 
safely if needed.
International donors: Organizations which 
extend across national boundaries and which give 
funds for projects of a developmental nature.
Intervention: Any measure whose purpose is to 
improve health or alter the course of disease.
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Legislation: A law, or laws, enacted by the 
governing bodies in a country.
Marketing: Any form of commercial 
communication or message that is designed to, or 
has the effect of, increasing the recognition, appeal 
and/or consumption of particular products and 
services. It comprises anything that acts to advertise 
or otherwise promote a product or service.
Multisectoral: Involving different sectors, such as 
health, agriculture, education, finance, infrastructure, 
transport, trade, etc.
Multisectoral collaboration: A recognized 
relationship between part of parts of different sectors of 
society, such as ministries (e.g. of health or education), 
agencies, NGOs, private for-profit sector and 
community representation) which have been formed to 
take action to achieve health outcomes in a way which 
is more effective, efficient or sustainable than might be 
achieved by the health sector acting alone. 
Multistakeholder: Involving stakeholders from 
across the public sector, civil society, NGOs and the 
private sector.
National Cancer Screening Programme: 
A government-endorsed programme whereby 
screening is offered. (NGO-led programmes or 
national recommendations for screening at the 
patient’s cost, do not qualify as a national screening 
programme.)
National focal point, unit/department:
I. National focal point: the person responsible 
for prevention and control of chronic diseases 
within a ministry of health or national institute.
II. Unit or department: a unit or department 
with responsibility for NCD disease prevention 
and control within a ministry of health or national 
institute.
National health reporting system, survey 
and surveillance: 
I. National health reporting system: the 
process by which a ministry of health produces 
annual health reports that summarize data on, 
for example, national health human resources, 
population demographics, health expenditures, 
health indicators such as mortality and morbidity. 
This includes the process of collecting data from 
various health information sources e.g. disease 
registries, hospital admission or discharge data.
II. National survey: a survey, of fixed or unfixed 
time interval, on the main chronic diseases, or 
major risk factors common to chronic diseases.
III. Surveillance: the systematic collection of data 
(through survey or registration) on risk factors, 
chronic diseases and their determinants for 
continuous analysis, interpretation and feed-back. 
National integrated action plan: A concerted 
approach to addressing a multiplicity of issues 
within a chronic disease prevention and health 
promotion framework, targeting the major risk 
factors common to the main chronic diseases, 
including the integration of primary, secondary 
and tertiary prevention, health promotion and 
diseases prevention programmes across sectors and 
disciplines.
National policy, strategy or action plan:
I. Policy: a specific official decision or set of 
decisions designed to carry out a course of action 
endorsed by a political body, including a set of 
goals, priorities and main directions for attaining 
these goals. The policy document may include a 
strategy to give effect to the policy.
II. Strategy: a long term plan designed to achieve 
a particular goal. 
III. Action plan: a scheme or course of action, 
which may correspond to a policy or strategy, 
with defined activities indicating who does what 
(type of activities and people responsible for 
implementation), when (timeframe), how, and 
with what resources to accomplish an objective.
National protocols, guidelines or 
standards for chronic diseases and 
conditions: A recommended evidence-based 
course of action to prevent a chronic disease 
or condition or to treat or manage a chronic 
disease or condition with the aim of preventing 
complications and improving outcomes and the 
quality of life of patients.
NGO: Nongovernmental organization.
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Noncommunicable diseases (NCDs): The 
four main types of noncommunicable diseases 
– cardiovascular diseases (such as heart attacks 
and stroke), cancers, chronic respiratory diseases 
(such as chronic obstructed pulmonary disease and 
asthma), and diabetes.
Noncommunicable diseases prevention 
and control: All activities related to surveillance, 
prevention and management of the chronic NCDs.
Not in effect: Any policy, strategy or plan of 
action which has been previously developed, and is 
either no longer under development, or for various 
reasons is not being implemented.
Nutrition labelling: A description intended 
to inform consumers of nutritional properties 
of food, consisting of two components: (i) 
nutrient declaration; (ii) supplementary nutrition 
information.
Operational: A policy, strategy or plan of action 
which is being used and implemented in the 
country, and has resources and funding available 
for implementation.
Partnership for health: An agreement between 
two or more partners to work cooperatively towards 
a set of shared health outcomes.
Price subsidies: Economic benefit provided by the 
government (such as a tax allowance or duty rebate) 
to keep the price of healthy foods low.
Primary prevention: Measures directed towards 
preventing the initial occurrence of a disease or 
disorder.
Print media: Communicating with the public 
through printed materials such as magazines, 
newspapers and billboards.
Product reformulation by industry: The 
process of changing the composition of processed 
foods to be healthier, with a reduced salt content.
Public awareness programme: A comprehensive 
effort that includes multiple components (messaging, 
grassroots outreach, media relations, government 
affairs, budget, etc.) to help increase public 
understanding about the importance of an issue.
Public health sector: Publicly funded health-care 
sector.
Rehabilitation: A set of measures that assist 
individuals who experience, or are likely to 
experience, disability to achieve and maintain 
optimal functioning in interaction with their 
environments. 
Rehabilitation services: services that include 
rehabilitation medicine, therapy and assistive 
technology.
Risk factors associated with NCDs: The four 
main risk factors for NCDs – tobacco use, harmful 
use of alcohol, unhealthy diet, and low levels of 
physical activity. 
Sample registration system: A method and 
procedure for estimating vital statistics in national 
and regional populations by intensively registering 
and verifying vital events in population samples. 
In India, for example, more than 4000 rural and 
2000 urban sample units, with a total of more 
than 6 million individuals (i.e. less than 1% of the 
total national population) are included in a sample 
registration system that provides a reasonably 
reliable picture of the national pattern of vital events 
at a cost that is feasible and realistic.
Saturated fats: Fats found in animal products, 
including meat and whole milk dairy products, as 
well as certain plant oils such as palm, palm kernel 
and coconut oils.
Screening: Measures preformed across an 
apparently healthy population in order to identify 
individuals who have risk factor or early stages of 
disease, but do not yet show symptoms.
Screening coverage: The proportion of people 
in the population targeted by the programme who 
actually received screening in the timeframe defined 
by the programme. (For example, if a country 
recommends mammography screening every 2 
years for women aged 50–60 years, the screening 
coverage is the number of women in the 50–60 age 
group who benefitted from mammography in the 
past 2 years as a result of the programme, divided 
by the total number of women in the country aged 
50–60 years.)
Self-regulation: In the context of this survey refers 
to when group or private sector entity governs or 
polices itself without outside assistance or influence.
Target: A specific aim to be achieved that should 
be time-bound, and define a “desired”, “promised”, 
“minimum” or “aspirational” level of achievement.
Taxation incentives to promote physical 
activity: Incentives that involve removing the tax (or 
a portion of the tax) in order to promote increased 
use of goods or services to encourage physical 
activity. 
Trans-fatty acids (trans fats): A form of fatty 
acids. While trans fats occur in tiny amounts in some 
foods, almost all trans fats result from an industrial 
process that partially hydrogenates (adds hydrogen 
to) unsaturated fatty acids. Trans fats are thus a form 
of processed vegetable oils. 
Under development: Something, such as 
a policy, action plan or strategy, which is still 
being developed or finalized and is not yet being 
implemented in the country. 
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